Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_000157.3(GBA):c.[1197G>T];[1603C>T]			Gaucher disease type I	Likely pathogenic(Last reviewed: Oct 1, 2015)	no assertion criteria provided	VCV000424820					424820			
NM_000157.3(GBA):c.[1448T>C];[167T>G]			Gaucher disease type I	Likely pathogenic(Last reviewed: Sep 25, 2015)	no assertion criteria provided	VCV000424819					424819			
NM_000157.3(GBA):c.[1448T>C];[407C>T]			Gaucher disease type I	Likely pathogenic(Last reviewed: Sep 25, 2015)	no assertion criteria provided	VCV000424818					424818			
NM_177924.5(ASAH1):c.502G>T (p.Gly168Trp)	ASAH1	G162W, G184W, G103W, G168W	Farber lipogranulomatosis	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000812477	8	17920695	8	18063186	812477	800731	rs1421841663	NC_000008.11:18063185:C:A
NM_000057.4(BLM):c.2207_2212delinsTAGATTC (p.Tyr736fs)	BLM	Y736fs, Y361fs	Bloom syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000005454	15	91310153 - 91310158	15	90766923 - 90766928	5454	20493	rs113993962	NC_000015.10:90766922:ATCTGA:TAGATTC
NM_002778.4(PSAP):c.*238G>C	CDH23|PSAP		Usher syndrome type 1D|Deafness, autosomal recessive 12|Gaucher disease, atypical, due to saposin C deficiency|Combined saposin deficiency|Krabbe disease, atypical, due to saposin A deficiency|Sphingolipid activator protein 1 deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000879308	10	73576960	10	71817203	879308	866175		NC_000010.11:71817202:C:G
NM_022124.6(CDH23):c.*478G>C	CDH23|PSAP		Combined saposin deficiency|Deafness, autosomal recessive 12|Usher syndrome type 1D|Galactosylceramide beta-galactosidase deficiency|Metachromatic leukodystrophy|Atypical Gaucher Disease	Conflicting interpretations of pathogenicity(Last reviewed: Apr 27, 2017)	criteria provided, conflicting interpretations	VCV000368919	10	73575513	10	71815756	368919	353148	rs564392413	NC_000010.11:71815755:G:C
NM_022124.6(CDH23):c.*439C>T	CDH23|PSAP		Combined saposin deficiency|Usher syndrome type 1D|Deafness, autosomal recessive 12|Metachromatic leukodystrophy|Atypical Gaucher Disease|Galactosylceramide beta-galactosidase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000368918	10	73575474	10	71815717	368918	353147	rs140312023	NC_000010.11:71815716:C:T
NM_022124.6(CDH23):c.*80G>A	CDH23|PSAP		Combined saposin deficiency|Deafness, autosomal recessive 12|Usher syndrome type 1D|Metachromatic leukodystrophy|Atypical Gaucher Disease|Galactosylceramide beta-galactosidase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000368910	10	73575115	10	71815358	368910	353139	rs75715348	NC_000010.11:71815357:G:A
NM_022124.6(CDH23):c.9983G>A (p.Arg3328His)	CDH23|PSAP	R3328H, R1088H, R1053H, R190H, R225H	Galactosylceramide beta-galactosidase deficiency|not specified|Combined saposin deficiency|Usher syndrome type 1D|Usher syndrome type 1|Deafness, autosomal recessive 12|Metachromatic leukodystrophy|Atypical Gaucher Disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2019)	criteria provided, conflicting interpretations	VCV000368908	10	73574953	10	71815196	368908	353137	rs148475933	NC_000010.11:71815195:G:A
NM_002778.4(PSAP):c.*891G>A	CDH23|PSAP		not provided|Nonsyndromic Hearing Loss, Recessive|Krabbe disease, atypical, due to saposin A deficiency|Gaucher disease, atypical, due to saposin C deficiency|Combined saposin deficiency|Sphingolipid activator protein 1 deficiency|Retinitis pigmentosa-deafness syndrome	Benign/Likely benign(Last reviewed: May 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000300498	10	73576307	10	71816550	300498	316048	rs7869	NC_000010.11:71816549:C:T
NM_022124.6(CDH23):c.*515C>A	CDH23|PSAP		Retinitis pigmentosa-deafness syndrome|Deafness, autosomal recessive 12|Nonsyndromic Hearing Loss, Recessive|Atypical Gaucher Disease|Combined saposin deficiency|Usher syndrome type 1D|Galactosylceramide beta-galactosidase deficiency|Metachromatic leukodystrophy	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000300494	10	73575550	10	71815793	300494	316047	rs16929375	NC_000010.11:71815792:C:A
NM_022124.6(CDH23):c.*510G>A	CDH23|PSAP		Deafness, autosomal recessive 12|not provided|Metachromatic leukodystrophy|Usher syndrome type 1D|Nonsyndromic Hearing Loss, Recessive|Combined saposin deficiency|Atypical Gaucher Disease|Galactosylceramide beta-galactosidase deficiency|Retinitis pigmentosa-deafness syndrome	Benign/Likely benign(Last reviewed: May 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000300493	10	73575545	10	71815788	300493	322108	rs1054635	NC_000010.11:71815787:G:A
NM_022124.6(CDH23):c.*434G>A	CDH23|PSAP		Deafness, autosomal recessive 12|Usher syndrome type 1D|Nonsyndromic Hearing Loss, Recessive|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency|Sphingolipid activator protein 1 deficiency|Gaucher disease, atypical, due to saposin C deficiency|Retinitis pigmentosa-deafness syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000300492	10	73575469	10	71815712	300492	322106	rs529522213	NC_000010.11:71815711:G:A
NM_022124.6(CDH23):c.*430A>T	CDH23|PSAP		Deafness, autosomal recessive 12|Usher syndrome type 1D|Nonsyndromic Hearing Loss, Recessive|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency|Sphingolipid activator protein 1 deficiency|Gaucher disease, atypical, due to saposin C deficiency|CDH23-Related Disorders|Retinitis pigmentosa-deafness syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000300491	10	73575465	10	71815708	300491	322105	rs562268606	NC_000010.11:71815707:A:T
NM_022124.6(CDH23):c.*361C>A	CDH23|PSAP		Retinitis pigmentosa-deafness syndrome|Nonsyndromic Hearing Loss, Recessive|Atypical Gaucher Disease|Combined saposin deficiency|Deafness, autosomal recessive 12|Usher syndrome type 1D|Galactosylceramide beta-galactosidase deficiency|Metachromatic leukodystrophy	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000300490	10	73575396	10	71815639	300490	322102	rs115033851	NC_000010.11:71815638:C:A
NM_022124.6(CDH23):c.*349A>G	CDH23|PSAP		Retinitis pigmentosa-deafness syndrome|Metachromatic leukodystrophy|Nonsyndromic Hearing Loss, Recessive|Atypical Gaucher Disease|Combined saposin deficiency|Deafness, autosomal recessive 12|Usher syndrome type 1D|Galactosylceramide beta-galactosidase deficiency|not provided	Benign/Likely benign(Last reviewed: May 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000300489	10	73575384	10	71815627	300489	316044	rs1867978	NC_000010.11:71815626:A:G
NM_022124.6(CDH23):c.*204A>G	CDH23|PSAP		not provided|Metachromatic leukodystrophy|Deafness, autosomal recessive 12|Usher syndrome type 1D|Nonsyndromic Hearing Loss, Recessive|Combined saposin deficiency|Atypical Gaucher Disease|Galactosylceramide beta-galactosidase deficiency|Retinitis pigmentosa-deafness syndrome	Benign/Likely benign(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000300488	10	73575239	10	71815482	300488	322726	rs2290022	NC_000010.11:71815481:A:G
NM_022124.6(CDH23):c.*141G>A	CDH23|PSAP		Retinitis pigmentosa-deafness syndrome|Nonsyndromic Hearing Loss, Recessive|Metachromatic leukodystrophy|Atypical Gaucher Disease|CDH23-Related Disorders|Combined saposin deficiency|Deafness, autosomal recessive 12|Galactosylceramide beta-galactosidase deficiency|Usher syndrome type 1D	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000300487	10	73575176	10	71815419	300487	322725	rs535544696	NC_000010.11:71815418:G:A
NM_022124.6(CDH23):c.*104G>C	CDH23|PSAP		Retinitis pigmentosa-deafness syndrome|Nonsyndromic Hearing Loss, Recessive|Atypical Gaucher Disease|Combined saposin deficiency|Deafness, autosomal recessive 12|Usher syndrome type 1D|Galactosylceramide beta-galactosidase deficiency|Metachromatic leukodystrophy	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000300485	10	73575139	10	71815382	300485	322714	rs377312107	NC_000010.11:71815381:G:C
NM_022124.6(CDH23):c.*68G>C	CDH23|PSAP		Retinitis pigmentosa-deafness syndrome|Nonsyndromic Hearing Loss, Recessive|Atypical Gaucher Disease|CDH23-Related Disorders|Combined saposin deficiency|Deafness, autosomal recessive 12|Usher syndrome type 1D|Galactosylceramide beta-galactosidase deficiency|Metachromatic leukodystrophy	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000300482	10	73575103	10	71815346	300482	310745	rs527311705	NC_000010.11:71815345:G:C
NM_022124.6(CDH23):c.9860G>A (p.Gly3287Asp)	CDH23|PSAP	G3287D, G149D, G1047D, G1012D, G184D	Retinitis pigmentosa-deafness syndrome|Nonsyndromic Hearing Loss, Recessive|Atypical Gaucher Disease|CDH23-Related Disorders|Combined saposin deficiency|Deafness, autosomal recessive 12|Usher syndrome type 1D|Metachromatic leukodystrophy|not specified|Galactosylceramide beta-galactosidase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000300477	10	73574830	10	71815073	300477	316010	rs562590210	NC_000010.11:71815072:G:A
NM_022124.6(CDH23):c.9739-12G>A	CDH23|PSAP		Retinitis pigmentosa-deafness syndrome|Nonsyndromic Hearing Loss, Recessive|Atypical Gaucher Disease|CDH23-Related Disorders|Combined saposin deficiency|Deafness, autosomal recessive 12|Usher syndrome type 1D|Galactosylceramide beta-galactosidase deficiency|not provided|Metachromatic leukodystrophy	Conflicting interpretations of pathogenicity(Last reviewed: Nov 25, 2020)	criteria provided, conflicting interpretations	VCV000300475	10	73574697	10	71814940	300475	310742	rs200638595	NC_000010.11:71814939:G:A
NM_022124.6(CDH23):c.9291G>T (p.Lys3097Asn)	CDH23|PSAP	K3097N, K857N	Retinitis pigmentosa-deafness syndrome|Nonsyndromic Hearing Loss, Recessive|Atypical Gaucher Disease|CDH23-Related Disorders|Combined saposin deficiency|Deafness, autosomal recessive 12|Usher syndrome type 1D|Galactosylceramide beta-galactosidase deficiency|Metachromatic leukodystrophy	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000300473	10	73571482	10	71811725	300473	316006	rs368441850	NC_000010.11:71811724:G:T
NM_002778.4(PSAP):c.1350+5G>A	CDH23|PSAP		not provided|Galactosylceramide beta-galactosidase deficiency|not specified|Retinitis pigmentosa-deafness syndrome|Atypical Gaucher Disease|Nonsyndromic Hearing Loss, Recessive|Gaucher disease, atypical, due to saposin C deficiency|Combined saposin deficiency|Krabbe disease, atypical, due to saposin A deficiency|Sphingolipid activator protein 1 deficiency|Metachromatic leukodystrophy	Benign/Likely benign(Last reviewed: Jul 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000258809	10	73579217	10	71819460	258809	253830	rs11000016	NC_000010.11:71819459:C:T
NM_022124.6(CDH23):c.9510+13C>T	CDH23|PSAP		Usher syndrome type 1D|Metachromatic leukodystrophy|Galactosylceramide beta-galactosidase deficiency|Combined saposin deficiency|not provided|Usher syndrome type 1|Deafness, autosomal recessive 12|Atypical Gaucher Disease|not specified	Benign/Likely benign(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000178843	10	73572379	10	71812622	178843	175007	rs183692794	NC_000010.11:71812621:C:T
NM_022124.6(CDH23):c.10026C>T (p.Asp3342=)	CDH23|PSAP		Usher syndrome type 1D|Galactosylceramide beta-galactosidase deficiency|Combined saposin deficiency|not provided|Retinitis pigmentosa-deafness syndrome|Deafness, autosomal recessive 12|Metachromatic leukodystrophy|CDH23-Related Disorders|Atypical Gaucher Disease|Nonsyndromic Hearing Loss, Recessive|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)	criteria provided, conflicting interpretations	VCV000178317	10	73574996	10	71815239	178317	175289	rs377118941	NC_000010.11:71815238:C:T
NM_022124.6(CDH23):c.9629T>C (p.Ile3210Thr)	CDH23|PSAP	I3210T, I107T, I970T	Metachromatic leukodystrophy|Galactosylceramide beta-galactosidase deficiency|not provided|Combined saposin deficiency|Usher syndrome type 1|Retinitis pigmentosa-deafness syndrome|Usher syndrome type 1D|Atypical Gaucher Disease|Nonsyndromic Hearing Loss, Recessive|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 10, 2021)	criteria provided, conflicting interpretations	VCV000178315	10	73572643	10	71812886	178315	175287	rs144688588	NC_000010.11:71812885:T:C
NM_022124.6(CDH23):c.9510+19_9510+25del	CDH23|PSAP		Combined saposin deficiency|Usher syndrome type 1D|Atypical Gaucher Disease|Galactosylceramide beta-galactosidase deficiency|Metachromatic leukodystrophy|not provided|not specified|Usher syndrome type 1	Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2020)	criteria provided, conflicting interpretations	VCV000133306	10	73572382 - 73572388	10	71812625 - 71812631	133306	137043	rs149704197	NC_000010.11:71812624:TCAGGCATCA:TCA
NM_002778.4(PSAP):c.1351-14A>G	CDH23|PSAP		Metachromatic leukodystrophy|Galactosylceramide beta-galactosidase deficiency|not specified|not provided|Sphingolipid activator protein 1 deficiency|Gaucher disease, atypical, due to saposin C deficiency|Combined saposin deficiency|Krabbe disease, atypical, due to saposin A deficiency|CDH23-Related Disorders|Atypical Gaucher Disease	Benign/Likely benign(Last reviewed: Jul 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000094085	10	73578882	10	71819125	94085	99987	rs4747203	NC_000010.11:71819124:T:C
NM_022124.6(CDH23):c.9978C>T (p.Asn3326=)	CDH23|PSAP		Combined saposin deficiency|not provided|Deafness, autosomal recessive 12|Galactosylceramide beta-galactosidase deficiency|Usher syndrome type 1D|Metachromatic leukodystrophy|not specified|Atypical Gaucher Disease|Usher syndrome type 1	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000046082	10	73574948	10	71815191	46082	55247	rs73277900	NC_000010.11:71815190:C:T
NM_022124.6(CDH23):c.9903C>T (p.Pro3301=)	CDH23|PSAP		Deafness, autosomal recessive 12|Galactosylceramide beta-galactosidase deficiency|Combined saposin deficiency|not specified|not provided|Metachromatic leukodystrophy|Usher syndrome type 1|Atypical Gaucher Disease|Usher syndrome type 1D	Conflicting interpretations of pathogenicity(Last reviewed: Jul 1, 2021)	criteria provided, conflicting interpretations	VCV000046081	10	73574873	10	71815116	46081	55246	rs55717455	NC_000010.11:71815115:C:T
NM_022124.6(CDH23):c.9873G>A (p.Thr3291=)	CDH23|PSAP		Galactosylceramide beta-galactosidase deficiency|Nonsyndromic Hearing Loss, Recessive|Combined saposin deficiency|not specified|Metachromatic leukodystrophy|Usher syndrome type 1|Atypical Gaucher Disease|Retinitis pigmentosa-deafness syndrome|Deafness, autosomal recessive 12|Usher syndrome type 1D|not provided	Benign/Likely benign(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000046080	10	73574843	10	71815086	46080	55245	rs2290021	NC_000010.11:71815085:G:A
NM_022124.6(CDH23):c.9758A>C (p.Asp3253Ala)	CDH23|PSAP	D3253A, D1013A, D150A, D115A, D978A	Usher syndrome type 1D|Galactosylceramide beta-galactosidase deficiency|Usher syndrome type 1|not specified|Combined saposin deficiency|not provided|Metachromatic leukodystrophy|Atypical Gaucher Disease|Deafness, autosomal recessive 12	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000046079	10	73574728	10	71814971	46079	55244	rs140463385	NC_000010.11:71814970:A:C
NM_022124.6(CDH23):c.9501G>A (p.Thr3167=)	CDH23|PSAP		Usher syndrome type 1|Combined saposin deficiency|Deafness, autosomal recessive 12|Metachromatic leukodystrophy|Usher syndrome type 1D|Galactosylceramide beta-galactosidase deficiency|not provided|not specified|Atypical Gaucher Disease	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)	criteria provided, conflicting interpretations	VCV000046074	10	73572357	10	71812600	46074	55239	rs144906721	NC_000010.11:71812599:G:A
NM_022124.6(CDH23):c.9373T>C (p.Phe3125Leu)	CDH23|PSAP	F3125L, F885L	none provided|Combined saposin deficiency|not provided|Deafness, autosomal recessive 12|Metachromatic leukodystrophy|Retinitis pigmentosa-deafness syndrome|Usher syndrome type 1|Galactosylceramide beta-galactosidase deficiency|not specified|Nonsyndromic Hearing Loss, Recessive|Usher syndrome type 1D|Atypical Gaucher Disease	Benign/Likely benign(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000046072	10	73571765	10	71812008	46072	55237	rs45583140	NC_000010.11:71812007:T:C
NM_022124.6(CDH23):c.9319+11G>A	CDH23|PSAP		Combined saposin deficiency|not specified|Deafness, autosomal recessive 12|Metachromatic leukodystrophy|not provided|Retinitis pigmentosa-deafness syndrome|Galactosylceramide beta-galactosidase deficiency|Nonsyndromic Hearing Loss, Recessive|Usher syndrome type 1D|Atypical Gaucher Disease	Benign/Likely benign(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000046071	10	73571521	10	71811764	46071	55236	rs11000013	NC_000010.11:71811763:G:A
NM_000492.4(CFTR):c.350G>A (p.Arg117His)	CFTR	R117H	not provided|Hereditary pancreatitis|ivacaftor response - Efficacy|Cystic fibrosis|Obstructive azoospermia|Congenital bilateral aplasia of vas deferens from CFTR mutation|Inborn genetic diseases|CFTR-related disorders|Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|Hereditary pancreatitis|Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis	Pathogenic(Last reviewed: Mar 3, 2004)	practice guideline	VCV000007109	7	117171029	7	117530975	7109	22148	rs78655421	NC_000007.14:117530974:G:A
NM_003465.3(CHIT1):c.1155_1156+2del	CHIT1		not provided|Chitotriosidase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2020)	criteria provided, conflicting interpretations	VCV000294917	1	203186865 - 203186868	1	203217737 - 203217740	294917	278476	rs143439055	NC_000001.11:203217736:ACTCA:A
NM_003465.3(CHIT1):c.304G>A (p.Gly102Ser)	CHIT1	G102S	Chitotriosidase deficiency|not provided	Benign(Last reviewed: Mar 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009526	1	203194186	1	203225058	9526	24565	rs2297950	NC_000001.11:203225057:C:T
NM_003465.3(CHIT1):c.220G>A (p.Glu74Lys)	CHIT1	E74K	Chitotriosidase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Aug 9, 2019)	criteria provided, conflicting interpretations	VCV000009525	1	203194834	1	203225706	9525	24564	rs137852607	NC_000001.11:203225705:C:T
CHIT1, GLY354ARG, LEU385LEU, AND 4-BP DEL	CHIT1		Chitotriosidase deficiency	Affects(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000009524					9524	24563		
CHIT1, 24-BP DUP	CHIT1		Chitotriosidase deficiency	Affects(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000009523					9523	24562		
NM_003640.5(ELP1):c.3195G>A (p.Ala1065=)	ELP1		Gaucher disease	Uncertain significance(Last reviewed: Apr 23, 2020)	no assertion criteria provided	VCV000989521	9	111651639	9	108889359	989521	978515		NC_000009.12:108889358:C:T
NM_000157.4(GBA):c.898G>A (p.Ala300Thr)	GBA|LOC106627981	A213T, A251T, A300T	Gaucher disease type I	Uncertain significance(Last reviewed: Jul 22, 2021)	criteria provided, single submitter	VCV001210414	1	155207233	1	155237442	1210414	1200414		NC_000001.11:155237441:C:T
NM_000157.4(GBA):c.1200G>A (p.Met400Ile)	GBA|LOC106627981	M313I, M351I, M400I	Gaucher disease type I	Uncertain significance(Last reviewed: Jul 22, 2021)	criteria provided, single submitter	VCV001210413	1	155206060	1	155236269	1210413	1200413		NC_000001.11:155236268:C:T
NM_000157.4(GBA):c.1455A>G (p.Ala485=)	GBA|LOC106627981		Gaucher disease type II|Gaucher disease type I	Uncertain significance(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV001199309	1	155205036	1	155235245	1199309	1189260		NC_000001.11:155235244:T:C
NM_000157.4(GBA):c.1255G>A (p.Asp419Asn)	GBA|LOC106627981	D332N, D370N, D419N	Gaucher disease type I	Likely pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV001184271	1	155205605	1	155235814	1184271	1174034		NC_000001.11:155235813:C:T
NM_000157.4(GBA):c.1506-12C>T	GBA|LOC106627981		not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 28, 2021)	criteria provided, conflicting interpretations	VCV001177278	1	155204903	1	155235112	1177278	1166559		NC_000001.11:155235111:G:A
NM_000157.4(GBA):c.604C>T (p.Arg202Ter)	GBA|LOC106627981	R115*, R153*, R202*	Gaucher disease|Hereditary late onset Parkinson disease	Pathogenic(Last reviewed: Sep 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV001119997	1	155208082	1	155238291	1119997	1108785		NC_000001.11:155238290:G:A
NM_000157.4(GBA):c.914C>T (p.Pro305Leu)	GBA|LOC106627981	P218L, P256L, P305L	Gaucher disease type I	Likely pathogenic(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001065557	1	155207217	1	155237426	1065557	1053860		NC_000001.11:155237425:G:A
NM_000157.4(GBA):c.145G>A (p.Gly49Ser)	GBA|LOC106627981	G49S	Gaucher disease, perinatal lethal	Uncertain significance(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV001028106	1	155209839	1	155240048	1028106	1015553		NC_000001.11:155240047:C:T
NM_000157.4(GBA):c.635C>G (p.Ser212Ter)	GBA|LOC106627981	S125*, S163*, S212*	Hereditary late onset Parkinson disease|Gaucher disease|not provided	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000996254	1	155208051	1	155238260	996254	983940		NC_000001.11:155238259:G:C
NM_000157.4(GBA):c.455-7T>C	GBA|LOC106627981		Gaucher disease	Uncertain significance(Last reviewed: Aug 14, 2020)	no assertion criteria provided	VCV000991406	1	155208448	1	155238657	991406	977446		NC_000001.11:155238656:A:G
NM_000157.4(GBA):c.730T>C (p.Tyr244His)	GBA|LOC106627981	Y157H, Y195H, Y244H	Gaucher disease	Uncertain significance(Last reviewed: Aug 14, 2020)	no assertion criteria provided	VCV000991405	1	155207956	1	155238165	991405	977445		NC_000001.11:155238164:A:G
NM_000157.4(GBA):c.1548G>C (p.Val516=)	GBA|LOC106627981		Gaucher disease	Uncertain significance(Last reviewed: Aug 14, 2020)	no assertion criteria provided	VCV000991404	1	155204849	1	155235058	991404	977444		NC_000001.11:155235057:C:G
NM_000157.4(GBA):c.1566C>T (p.Ile522=)	GBA|LOC106627981		Gaucher disease	Uncertain significance(Last reviewed: Aug 13, 2020)	no assertion criteria provided	VCV000991403	1	155204831	1	155235040	991403	977443		NC_000001.11:155235039:G:A
NM_000157.4(GBA):c.203dup (p.Thr69fs)	GBA|LOC106627981	T69fs	Gaucher disease	Pathogenic/Likely pathogenic(Last reviewed: Nov 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000987870	1	155209780 - 155209781	1	155239989 - 155239990	987870	975763		NC_000001.11:155239989:GGGGGG:GGGGGGG
NM_000157.4(GBA):c.941A>G (p.Asn314Ser)	GBA|LOC106627981	N227S, N265S, N314S	not specified	Uncertain significance(Last reviewed: Aug 3, 2020)	criteria provided, single submitter	VCV000977685	1	155207190	1	155237399	977685	965821		NC_000001.11:155237398:T:C
NM_000157.4(GBA):c.108G>A (p.Trp36Ter)	GBA	W36*	Gaucher disease	Pathogenic(Last reviewed: Jul 17, 2020)	criteria provided, single submitter	VCV000974986	1	155210428	1	155240637	974986	963246		NC_000001.11:155240636:C:T
NM_000157.4(GBA):c.1534A>T (p.Lys512Ter)	GBA|LOC106627981	K425*, K463*, K512*	Inborn genetic diseases|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 28, 2020)	criteria provided, conflicting interpretations	VCV000974979	1	155204863	1	155235072	974979	963245		NC_000001.11:155235071:T:A
NM_000157.4(GBA):c.403_404del (p.Leu135fs)	GBA|LOC106627981	L48fs, L135fs	Gaucher disease type I	Pathogenic	no assertion criteria provided	VCV000932298	1	155209457 - 155209458	1	155239666 - 155239667	932298	920601		NC_000001.11:155239665:AG:
NM_000157.4(GBA):c.1238A>C (p.His413Pro)	GBA|LOC106627981	H326P, H364P, H413P	Gaucher disease type I	Likely pathogenic	no assertion criteria provided	VCV000932296	1	155205622	1	155235831	932296	920599		NC_000001.11:155235830:T:G
NM_000157.4(GBA):c.1289C>T (p.Pro430Leu)	GBA|LOC106627981	P430L, P343L, P381L	Gaucher disease, perinatal lethal	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000931820	1	155205571	1	155235780	931820	918564		NC_000001.11:155235779:G:A
NM_000157.4(GBA):c.1389-33del	GBA|LOC106627981		Gaucher disease, perinatal lethal	Uncertain significance(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000930901	1	155205135	1	155235344	930901	920127		NC_000001.11:155235343:GGGG:GGG
NM_000157.4(GBA):c.34C>T (p.Pro12Ser)	GBA	P12S	Gaucher disease, perinatal lethal	Uncertain significance(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000930745	1	155210502	1	155240711	930745	918565		NC_000001.11:155240710:G:A
NM_000157.4(GBA):c.914del (p.Pro305fs)	GBA|LOC106627981	P218fs, P256fs, P305fs	Gaucher disease	Likely pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000928837	1	155207217	1	155237426	928837	916793		NC_000001.11:155237425:GG:G
NM_000157.4(GBA):c.689T>G (p.Val230Gly)	GBA|LOC106627981	V143G, V181G, V230G	not specified	Uncertain significance(Last reviewed: Apr 3, 2019)	criteria provided, single submitter	VCV000928835	1	155207997	1	155238206	928835	916795		NC_000001.11:155238205:A:C
NM_000157.4(GBA):c.1259G>A (p.Trp420Ter)	GBA|LOC106627981	W333*, W371*, W420*	Gaucher disease	Pathogenic(Last reviewed: May 10, 2021)	criteria provided, single submitter	VCV000918141	1	155205601	1	155235810	918141	915011		NC_000001.11:155235809:C:T
NM_000157.4(GBA):c.1184C>T (p.Ser395Phe)	GBA|LOC106627981	S308F, S346F, S395F	Gaucher disease	Pathogenic(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV000918140	1	155206076	1	155236285	918140	915012		NC_000001.11:155236284:G:A
NM_000157.4(GBA):c.1151C>T (p.Ser384Phe)	GBA|LOC106627981	S297F, S335F, S384F	Gaucher disease type I	Likely pathogenic(Last reviewed: Jun 4, 2020)	no assertion criteria provided	VCV000917863	1	155206109	1	155236318	917863	906183		NC_000001.11:155236317:G:A
NM_000157.4(GBA):c.1599G>A (p.Trp533Ter)	GBA|LOC106627981	W446*, W533*, W484*	Gaucher disease type I	Pathogenic(Last reviewed: Jun 4, 2020)	no assertion criteria provided	VCV000917862	1	155204798	1	155235007	917862	906182		NC_000001.11:155235006:C:T
NM_000157.4(GBA):c.557del (p.Phe186fs)	GBA|LOC106627981	F186fs, F137fs, F99fs	Gaucher disease type I	Pathogenic	no assertion criteria provided	VCV000869105	1	155208339	1	155238548	869105	857349		NC_000001.11:155238547:AA:A
NM_000157.4(GBA):c.1000-81A>C	GBA|LOC106627981		Gaucher disease	Benign(Last reviewed: May 20, 2019)	no assertion criteria provided	VCV000828082	1	155206341	1	155236550	828082	816426	rs9628662	NC_000001.11:155236549:T:G
NM_000157.4(GBA):c.929G>A (p.Ser310Asn)	GBA|LOC106627981	S223N, S261N, S310N	Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III	Likely pathogenic	criteria provided, single submitter	VCV000813339	1	155207202	1	155237411	813339	801585	rs74731340	NC_000001.11:155237410:C:T
NM_000157.4(GBA):c.946C>T (p.Arg316Cys)	GBA|LOC106627981	R229C, R267C, R316C	Hereditary late onset Parkinson disease|not provided|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C	Conflicting interpretations of pathogenicity(Last reviewed: May 3, 2021)	criteria provided, conflicting interpretations	VCV000813338	1	155207185	1	155237394	813338	801584	rs1264734195	NC_000001.11:155237393:G:A
NM_000157.4(GBA):c.970C>T (p.Arg324Cys)	GBA|LOC106627981	R275C, R324C, R237C	Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III	Pathogenic	criteria provided, single submitter	VCV000813337	1	155207161	1	155237370	813337	801583	rs765633380	NC_000001.11:155237369:G:A
NM_000157.4(GBA):c.1174C>T (p.Arg392Trp)	GBA|LOC106627981	R305W, R392W, R343W	Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III	Pathogenic	criteria provided, single submitter	VCV000813336	1	155206086	1	155236295	813336	801582	rs121908308	NC_000001.11:155236294:G:A
NM_000157.4(GBA):c.1388+2T>C	GBA|LOC106627981		Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III	Pathogenic	criteria provided, single submitter	VCV000813335	1	155205470	1	155235679	813335	801581	rs1571965880	NC_000001.11:155235678:A:G
NM_000157.4(GBA):c.247C>T (p.Arg83Cys)	GBA|LOC106627981	R83C	not provided	Uncertain significance(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000806230	1	155209737	1	155239946	806230	794438	rs1141812	NC_000001.11:155239945:G:A
NM_000157.4(GBA):c.1388G>C (p.Ser463Thr)	GBA|LOC106627981	S376T, S414T, S463T	Gaucher disease type I	Uncertain significance(Last reviewed: Feb 7, 2020)	criteria provided, single submitter	VCV000801555	1	155205472	1	155235681	801555	789853	rs1571965884	NC_000001.11:155235680:C:G
NM_000157.4(GBA):c.1347G>C (p.Thr449=)	GBA|LOC106627981		not provided|Gaucher disease	Likely benign(Last reviewed: Apr 19, 2017)	criteria provided, single submitter	VCV000770492	1	155205513	1	155235722	770492	696140	rs750193229	NC_000001.11:155235721:C:G
NM_000157.4(GBA):c.1316G>A (p.Ser439Asn)	GBA|LOC106627981	S352N, S390N, S439N	Gaucher disease type III|Gaucher disease type II|Gaucher disease, perinatal lethal|Gaucher disease type 3C|Gaucher disease type I	Uncertain significance(Last reviewed: Oct 10, 2019)	criteria provided, single submitter	VCV000694729	1	155205544	1	155235753	694729	682848	rs1571966221	NC_000001.11:155235752:C:T
NM_000157.4(GBA):c.1503C>G (p.Asn501Lys)	GBA|LOC106627981	N414K, N452K, N501K	Gaucher disease type II	Likely pathogenic(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000691989	1	155204988	1	155235197	691989	679732	rs755265316	NC_000001.11:155235196:G:C
NM_000157.4(GBA):c.999+242C>A	GBA|LOC106627981		Gaucher disease type I	Pathogenic	criteria provided, single submitter	VCV000689500	1	155206890	1	155237099	689500	677160	rs1571969643	NC_000001.11:155237098:G:T
NM_000157.4(GBA):c.222_224del (p.Thr75del)	GBA|LOC106627981	T75del	Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|not provided|Gaucher disease	Pathogenic(Last reviewed: Jan 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000642539	1	155209760 - 155209762	1	155239969 - 155239971	642539	626896	rs761621516	NC_000001.11:155239968:GTA:
NM_000157.4(GBA):c.1495G>C (p.Val499Leu)	GBA|LOC106627981	V499L, V450L, V412L	Gaucher disease type I|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 22, 2021)	criteria provided, conflicting interpretations	VCV000634558	1	155204996	1	155235205	634558	622301	rs369068553	NC_000001.11:155235204:C:G
NM_000157.4(GBA):c.1357C>T (p.Gln453Ter)	GBA|LOC106627981	Q453*, Q366*, Q404*	Gaucher disease	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000633241	1	155205503	1	155235712	633241	621056	rs1557901325	NC_000001.11:155235711:G:A
NM_000157.4(GBA):c.762-1G>C	GBA|LOC106627981		Gaucher disease|Parkinson disease, late-onset	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633240	1	155207370	1	155237579	633240	621703	rs1237637353	NC_000001.11:155237578:C:G
NM_000157.4(GBA):c.709A>G (p.Lys237Glu)	GBA|LOC106627981	K237E, K188E, K150E	Gaucher disease	Pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, single submitter	VCV000633239	1	155207977	1	155238186	633239	621058	rs773409311	NC_000001.11:155238185:T:C
NM_000157.4(GBA):c.595_596del (p.Leu199fs)	GBA|LOC106627981	L150fs, L199fs, L112fs	not provided|Gaucher disease	Pathogenic(Last reviewed: Mar 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000632835	1	155208090 - 155208091	1	155238299 - 155238300	632835	621060	rs749714463	NC_000001.11:155238298:AG:
NM_000157.4(GBA):c.653G>A (p.Trp218Ter)	GBA|LOC106627981	W218*, W169*, W131*	Thrombocytopenia|Abnormal bleeding|Hereditary late onset Parkinson disease|Gaucher disease	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000632834	1	155208033	1	155238242	632834	621059	rs867929413	NC_000001.11:155238241:C:T
NM_000157.4(GBA):c.497A>T (p.Asp166Val)	GBA|LOC106627981	D166V, D117V, D79V	Gaucher disease	Likely pathogenic(Last reviewed: Apr 16, 2021)	criteria provided, single submitter	VCV000632833	1	155208399	1	155238608	632833	621061	rs79796061	NC_000001.11:155238607:T:A
NM_000157.4(GBA):c.1250G>A (p.Trp417Ter)	GBA|LOC106627981	W417*, W330*, W368*	Gaucher disease	Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000632832	1	155205610	1	155235819	632832	621057	rs754743440	NC_000001.11:155235818:C:T
NM_000157.4(GBA):c.1271T>C (p.Leu424Pro)	GBA|LOC106627981	L424P, L337P, L375P	Gaucher disease type I	Likely pathogenic(Last reviewed: Feb 20, 2017)	criteria provided, single submitter	VCV000623174	1	155205589	1	155235798	623174	612077	rs772548282	NC_000001.11:155235797:A:G
NM_000157.4(GBA):c.886C>T (p.Arg296Ter)	GBA|LOC106627981	R296*, R247*, R209*	Gaucher disease|not provided	Pathogenic(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000558787	1	155207245	1	155237454	558787	549499	rs1553217626	NC_000001.11:155237453:G:A
NM_000157.4(GBA):c.104C>T (p.Ser35Leu)	GBA	S35L	Gaucher disease|Gaucher disease type I	Uncertain significance(Last reviewed: May 3, 2020)	criteria provided, single submitter	VCV000522661	1	155210432	1	155240641	522661	513234	rs757041827	NC_000001.11:155240640:G:A
NM_000157.4(GBA):c.1279G>T (p.Glu427Ter)	GBA|LOC106627981	E427*, E340*, E378*	Gaucher disease	Likely pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000505377	1	155205581	1	155235790	505377	496141	rs149171124	NC_000001.11:155235789:C:A
NM_000157.4(GBA):c.1224G>A (p.Thr408=)	GBA|LOC106627981		Gaucher disease type II|Gaucher disease type I|not provided	Uncertain significance(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000503740	1	155206036	1	155236245	503740	495063	rs138498426	NC_000001.11:155236244:C:T
NM_000157.4(GBA):c.630del (p.Val211fs)	GBA|LOC106627981	V162fs, V211fs, V124fs	Gaucher disease	Pathogenic(Last reviewed: Feb 16, 2017)	criteria provided, single submitter	VCV000496084	1	155208056	1	155238265	496084	486844	rs1553217879	NC_000001.11:155238264:GGG:GG
NM_000157.4(GBA):c.1312G>A (p.Asp438Asn)	GBA|LOC106627981	D438N, D389N, D351N	not provided|Gaucher disease	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000496081	1	155205548	1	155235757	496081	486866	rs1553217009	NC_000001.11:155235756:C:T
NM_000157.4(GBA):c.1052G>C (p.Trp351Ser)	GBA|LOC106627981	W351S, W302S, W264S	Gaucher disease	Likely pathogenic(Last reviewed: Aug 29, 2016)	criteria provided, single submitter	VCV000496080	1	155206208	1	155236417	496080	486867	rs1553217294	NC_000001.11:155236416:C:G
NM_000157.4(GBA):c.1029del (p.Lys342_Tyr343insTer)	GBA|LOC106627981		Gaucher disease	Pathogenic(Last reviewed: Nov 18, 2016)	criteria provided, single submitter	VCV000496079	1	155206231	1	155236440	496079	486838	rs1553217314	NC_000001.11:155236439:A:
NM_000157.4(GBA):c.526G>A (p.Asp176Asn)	GBA|LOC106627981	D176N, D127N, D89N	Gaucher disease type I	Pathogenic(Last reviewed: Apr 4, 2012)	no assertion criteria provided	VCV000446213	1	155208370	1	155238579	446213	439574	rs1553217946	NC_000001.11:155238578:C:T
NM_000157.4(GBA):c.1102C>T (p.Arg368Cys)	GBA|LOC106627981	R368C, R281C, R319C	Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Gaucher disease|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 22, 2021)	criteria provided, conflicting interpretations	VCV000420153	1	155206158	1	155236367	420153	404945	rs374306700	NC_000001.11:155236366:G:A
NM_000157.4(GBA):c.521A>G (p.Tyr174Cys)	GBA|LOC106627981	Y174C, Y125C, Y87C	not provided|Gaucher disease	Likely pathogenic(Last reviewed: Aug 19, 2015)	criteria provided, single submitter	VCV000280972	1	155208375	1	155238584	280972	265209	rs781152868	NC_000001.11:155238583:T:C
NM_000157.4(GBA):c.454+47G>A	GBA|LOC106627981		Gaucher disease type I|Gaucher disease, perinatal lethal|not specified	Benign(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000256873	1	155209360	1	155239569	256873	249414	rs2075569	NC_000001.11:155239568:C:T
NM_000157.4(GBA):c.1225-34C>A	GBA|LOC106627981		Gaucher disease|not provided|Gaucher disease, perinatal lethal|not specified|Gaucher disease type I	Benign(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000256871	1	155205669	1	155235878	256871	249411	rs3115534	NC_000001.11:155235877:G:T
NM_000157.4(GBA):c.882T>G (p.His294Gln)	GBA|LOC106627981	H294Q, H245Q, H207Q	Gaucher disease type I|Gaucher disease type II|Gaucher disease type 3C|Gaucher disease type III|Gaucher disease, perinatal lethal|not provided|Gaucher disease type I|Gaucher disease	Conflicting interpretations of pathogenicity, other(Last reviewed: Jun 10, 2021)	criteria provided, conflicting interpretations	VCV000242810	1	155207249	1	155237458	242810	19373	rs367968666	NC_000001.11:155237457:A:C
NM_000157.4(GBA):c.866G>C (p.Gly289Ala)	GBA|LOC106627981	G289A, G202A, G240A	Gaucher disease type I	Likely pathogenic(Last reviewed: Apr 23, 2013)	no assertion criteria provided	VCV000236406	1	155207265	1	155237474	236406	237959	rs878853321	NC_000001.11:155237473:C:G
NM_000157.4(GBA):c.1397T>G (p.Ile466Ser)	GBA|LOC106627981	I466S, I417S, I379S	Gaucher disease type I	Likely pathogenic(Last reviewed: Mar 10, 2012)	no assertion criteria provided	VCV000236405	1	155205094	1	155235303	236405	237956	rs878853320	NC_000001.11:155235302:A:C
NM_000157.4(GBA):c.474C>T (p.Ile158=)	GBA|LOC106627981		Gaucher disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 20, 2021)	criteria provided, conflicting interpretations	VCV000225285	1	155208422	1	155238631	225285	227188	rs147411159	NC_000001.11:155238630:G:A
NM_000157.4(GBA):c.1093G>A (p.Glu365Lys)	GBA|LOC106627981	E365K, E278K, E316K	not provided|Parkinsonism|Parkinsonism|Tremor|Rigidity|Cogwheel rigidity|Parkinsonism|Neurological speech impairment|Hyperlipidemia|Lower limb muscle weakness|Dementia|Hypertensive disorder|not specified|Hereditary late onset Parkinson disease|Gaucher disease|Gaucher disease, perinatal lethal	Conflicting interpretations of pathogenicity, risk factor(Last reviewed: May 18, 2021)	criteria provided, conflicting interpretations	VCV000199044	1	155206167	1	155236376	199044	38432	rs2230288	NC_000001.11:155236375:C:T
NM_000157.4(GBA):c.896T>C (p.Ile299Thr)	GBA|LOC106627981	I299T, I212T, I250T	Gaucher disease|not provided	Likely pathogenic(Last reviewed: Sep 23, 2014)	criteria provided, single submitter	VCV000198757	1	155207235	1	155237444	198757	195917	rs794727908	NC_000001.11:155237443:A:G
NM_000157.4(GBA):c.437C>T (p.Ser146Leu)	GBA|LOC106627981	S146L, S59L	Gaucher disease|not provided	Uncertain significance(Last reviewed: Sep 5, 2014)	criteria provided, single submitter	VCV000197702	1	155209424	1	155239633	197702	194863	rs758447515	NC_000001.11:155239632:G:A
NM_000157.4(GBA):c.431T>G (p.Leu144Arg)	GBA|LOC106627981	L144R, L57R	Gaucher disease|not provided	Likely pathogenic(Last reviewed: Sep 23, 2014)	criteria provided, single submitter	VCV000197701	1	155209430	1	155239639	197701	194862	rs794727708	NC_000001.11:155239638:A:C
NM_000157.4(GBA):c.1265_1319del (p.Leu422fs)	GBA|LOC106627981	L335fs, L373fs, L422fs	Gaucher disease|not provided|Gaucher disease type I|Gaucher disease, perinatal lethal	Pathogenic(Last reviewed: Sep 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000193611	1	155205541 - 155205595	1	155235750 - 155235804	193611	190774	rs80356768	
NM_000157.4(GBA):c.721G>A (p.Gly241Arg)	GBA|LOC106627981	G241R, G154R, G192R	Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Gaucher disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000093459	1	155207965	1	155238174	93459	99364	rs409652	NC_000001.11:155238173:C:T
NM_000157.4(GBA):c.681T>G (p.Asn227Lys)	GBA|LOC106627981	N227K, N140K, N178K	Gaucher disease|Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|not provided	Pathogenic(Last reviewed: May 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000093458	1	155208005	1	155238214	93458	99363	rs381418	NC_000001.11:155238213:A:C
NM_000157.4(GBA):c.667T>C (p.Trp223Arg)	GBA|LOC106627981	W223R, W136R, W174R	Gaucher disease|not provided|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III	Pathogenic/Likely pathogenic(Last reviewed: Jun 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093457	1	155208019	1	155238228	93457	99362	rs61748906	NC_000001.11:155238227:A:G
NM_000157.4(GBA):c.625C>T (p.Arg209Cys)	GBA|LOC106627981	R209C, R160C, R122C	Gaucher disease|not provided|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000093455	1	155208061	1	155238270	93455	99360	rs398123532	NC_000001.11:155238269:G:A
NM_000157.4(GBA):c.508C>T (p.Arg170Cys)	GBA|LOC106627981	R170C, R121C, R83C	not provided|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Gaucher disease	Pathogenic(Last reviewed: Oct 16, 2013)	criteria provided, multiple submitters, no conflicts	VCV000093453	1	155208388	1	155238597	93453	99358	rs398123530	NC_000001.11:155238596:G:A
NM_000157.4(GBA):c.1448T>G (p.Leu483Arg)	GBA|LOC106627981	L483R, L434R, L396R	Gaucher disease|not provided|Gaucher disease type II|Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type I	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093449	1	155205043	1	155235252	93449	99356	rs421016	NC_000001.11:155235251:A:C
NM_000157.4(GBA):c.1240G>T (p.Val414Leu)	GBA|LOC106627981	V414L, V365L, V327L	not provided|Gaucher disease|Gaucher disease type I	Pathogenic/Likely pathogenic(Last reviewed: Jan 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093448	1	155205620	1	155235829	93448	99355	rs398123528	NC_000001.11:155235828:C:A
NM_000157.4(GBA):c.1223C>T (p.Thr408Met)	GBA|LOC106627981	T408M, T359M, T321M	not provided|not specified|Parkinson disease, late-onset|Gaucher disease, perinatal lethal|Gaucher disease	Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2021)	criteria provided, conflicting interpretations	VCV000093447	1	155206037	1	155236246	93447	99354	rs75548401	NC_000001.11:155236245:G:A
NM_000157.4(GBA):c.115+1G>A	GBA		Gaucher disease|not provided|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Lewy body dementia|Gaucher disease type 3C|Gaucher disease, perinatal lethal|Parkinson disease, late-onset|Parkinson disease, late-onset|Gaucher disease type II|Gaucher disease type I|Hereditary late onset Parkinson disease|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C	Pathogenic/Likely pathogenic(Last reviewed: Oct 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000093445	1	155210420	1	155240629	93445	99352	rs104886460	NC_000001.11:155240628:C:T
NM_000157.4(GBA):c.1060G>C (p.Asp354His)	GBA|LOC106627981	D354H, D267H, D305H	Gaucher disease|not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Oct 15, 2018)	criteria provided, conflicting interpretations	VCV000093444	1	155206200	1	155236409	93444	99351	rs398123526	NC_000001.11:155236408:C:G
NM_000157.4(GBA):c.475C>T (p.Arg159Trp)	GBA|LOC106627981	R159W, R110W, R72W	not provided|Gaucher disease	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000065570	1	155208421	1	155238630	65570	76478	rs439898	NC_000001.11:155238629:G:A
NM_000157.4(GBA):c.1226A>C (p.Asn409Thr)	GBA|LOC106627981	N409T, N322T, N360T	Gaucher disease	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000038301	1	155205634	1	155235843	38301	47036	rs76763715	NC_000001.11:155235842:T:G
NM_000157.4(GBA):c.93_94insG (p.Gln32fs)	GBA	Q32fs	Gaucher disease	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000021073	1	155210442 - 155210443	1	155240651 - 155240652	21073	33925	rs80356760	NC_000001.11:155240651::C
NM_000157.4(GBA):c.703T>C (p.Ser235Pro)	GBA|LOC106627981	S235P, S148P, S186P	Lewy body dementia|Gaucher disease|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C	Pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000021072	1	155207983	1	155238192	21072	33924	rs1064644	NC_000001.11:155238191:A:G
NM_000157.4(GBA):c.1505G>A (p.Arg502His)	GBA|LOC106627981	R502H, R453H, R415H	Gaucher disease|Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|not provided|Gaucher disease type I	Conflicting interpretations of pathogenicity(Last reviewed: Jan 24, 2020)	criteria provided, conflicting interpretations	VCV000021070	1	155204986	1	155235195	21070	33922	rs80356772	NC_000001.11:155235194:C:T
NM_000157.4(GBA):c.1444G>A (p.Asp482Asn)	GBA|LOC106627981	D395N, D433N, D482N	not specified|Parkinson disease, late-onset|not provided	Likely benign(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004335	1	155205047	1	155235256	4335	19374	rs75671029	NC_000001.11:155235255:C:T
NM_001005741.2(GBA):c.[880T>G;1342G>C]	GBA|LOC106627981	D448H, D361H, D399H, H294Q, H245Q, H207Q	Gaucher disease type II|Gaucher disease type III	Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	VCV000004334	1|1	155205518	1|1	155235727	4334	19332|19373	rs1064651|rs367968666	NC_000001.11:155235726:C:G|NC_000001.11:155237457:A:C
NM_000157.4(GBA):c.1506-1G>A	GBA|LOC106627981		Gaucher disease, perinatal lethal	Pathogenic(Last reviewed: Jul 15, 2004)	no assertion criteria provided	VCV000004333	1	155204892	1	155235101	4333	19372	rs1571964338	NC_000001.11:155235100:C:T
NM_000157.4(GBA):c.1228C>G (p.Leu410Val)	GBA|LOC106627981	L410V, L323V, L361V	Gaucher disease type I	Pathogenic(Last reviewed: Mar 15, 2004)	no assertion criteria provided	VCV000004332	1	155205632	1	155235841	4332	19371	rs121908314	NC_000001.11:155235840:G:C
NM_000157.4(GBA):c.870C>A (p.Phe290Leu)	GBA|LOC106627981	F251L, F290L, F203L, F241L	Gaucher disease, perinatal lethal	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000004331	1	155207261	1	155237470	4331	19370	rs121908313	NC_000001.11:155237469:G:T
NM_000157.4(GBA):c.354G>C (p.Lys118Asn)	GBA|LOC106627981	K118N, K31N	not provided|Gaucher disease type III|Gaucher disease type I	Pathogenic(Last reviewed: Jan 29, 2013)	criteria provided, single submitter	VCV000004330	1	155209507	1	155239716	4330	19369	rs121908312	NC_000001.11:155239715:C:G
NM_000157.4(GBA):c.509G>T (p.Arg170Leu)	GBA|LOC106627981	R170L, R121L, R83L	Gaucher disease, perinatal lethal|Gaucher disease	Pathogenic/Likely pathogenic(Last reviewed: Jan 13, 2020)	no assertion criteria provided	VCV000004329	1	155208387	1	155238596	4329	19368	rs80356763	NC_000001.11:155238595:C:A
NM_000157.4(GBA):c.887G>A (p.Arg296Gln)	GBA|LOC106627981	R296Q, R209Q, R247Q	not provided|Gaucher disease|Hereditary late onset Parkinson disease|Gaucher disease, perinatal lethal|Lewy body dementia|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Parkinson disease, late-onset|Gaucher disease type 3C|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C	Pathogenic(Last reviewed: Aug 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004328	1	155207244	1	155237453	4328	19367	rs78973108	NC_000001.11:155237452:C:T
NM_000157.4(GBA):c.1246G>A (p.Gly416Ser)	GBA|LOC106627981	G416S, G329S, G367S	not provided|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Abnormal bleeding|Thrombocytopenia|Gaucher disease type I|Gaucher disease|Gaucher disease type III	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004327	1	155205614	1	155235823	4327	19366	rs121908311	NC_000001.11:155235822:C:T
NM_000157.4(GBA):c.1192C>T (p.Arg398Ter)	GBA|LOC106627981	R398*, R349*, R311*	Gaucher disease|Gaucher disease type I|Gaucher disease, perinatal lethal|not provided	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004326	1	155206068	1	155236277	4326	19365	rs121908309	NC_000001.11:155236276:G:A
NM_000157.4(GBA):c.1049A>G (p.His350Arg)	GBA|LOC106627981	H311R, H350R, H301R, H263R	Gaucher disease, perinatal lethal	Pathogenic(Last reviewed: May 1, 1999)	no assertion criteria provided	VCV000004325	1	155206211	1	155236420	4325	19364	rs78198234	NC_000001.11:155236419:T:C
NM_000157.4(GBA):c.533del (p.Pro178fs)	GBA|LOC106627981	P178fs, P129fs, P91fs	Gaucher disease type I|Gaucher disease, perinatal lethal	Likely pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, single submitter	VCV000004322	1	155208363	1	155238572	4322	19361	rs397518434	NC_000001.11:155238571:GGGG:GGG
NM_000157.4(GBA):c.259C>T (p.Arg87Trp)	GBA|LOC106627981	R87W	not provided|Gaucher disease type I|Gaucher disease	Pathogenic(Last reviewed: Feb 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004321	1	155209725	1	155239934	4321	19360	rs1141814	NC_000001.11:155239933:G:A
NM_000157.4(GBA):c.1208G>C (p.Ser403Thr)	GBA|LOC106627981	S403T, S316T, S354T	Gaucher disease type I	Pathogenic/Likely pathogenic(Last reviewed: Jan 22, 2020)	no assertion criteria provided	VCV000004320	1	155206052	1	155236261	4320	19359	rs121908307	NC_000001.11:155236260:C:G
NM_000157.4(GBA):c.1090G>A (p.Gly364Arg)	GBA|LOC106627981	G364R, G277R, G315R	Gaucher disease|Gaucher disease, perinatal lethal|Gaucher disease type II|not provided	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000004318	1	155206170	1	155236379	4318	19357	rs121908305	NC_000001.11:155236378:C:T
NM_000157.4(GBA):c.1053G>T (p.Trp351Cys)	GBA|LOC106627981	W351C, W264C, W302C	Gaucher disease type I	Pathogenic(Last reviewed: Jul 1, 1990)	no assertion criteria provided	VCV000004317	1	155206207	1	155236416	4317	19356	rs121908304	NC_000001.11:155236415:C:A
NM_000157.4(GBA):c.763T>G (p.Phe255Val)	GBA|LOC106627981	F255V, F168V, F206V	Gaucher disease type I	Pathogenic(Last reviewed: Jun 21, 2017)	no assertion criteria provided	VCV000004315	1	155207368	1	155237577	4315	19354	rs121908303	NC_000001.11:155237576:A:C
NM_000157.4(GBA):c.680A>G (p.Asn227Ser)	GBA|LOC106627981	N227S, N140S, N178S	Gaucher disease type III|Gaucher disease|Gaucher disease type I|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004314	1	155208006	1	155238215	4314	19353	rs364897	NC_000001.11:155238214:T:C
NM_000157.4(GBA):c.160G>T (p.Val54Leu)	GBA|LOC106627981	V54L	Gaucher disease type I	Pathogenic(Last reviewed: Sep 11, 2018)	no assertion criteria provided	VCV000004313	1	155209824	1	155240033	4313	19352	rs121908302	NC_000001.11:155240032:C:A
NM_000157.4(GBA):c.1604G>A (p.Arg535His)	GBA|LOC106627981	R535H, R486H, R448H	Hereditary late onset Parkinson disease|not provided|Gaucher disease type I|Gaucher disease|Lewy body dementia|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Parkinson disease, late-onset|Gaucher disease type 3C|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004311	1	155204793	1	155235002	4311	19350	rs75822236	NC_000001.11:155235001:C:T
NM_000157.4(GBA):c.1549G>A (p.Gly517Ser)	GBA|LOC106627981	G517S, G430S, G468S	not provided|Gaucher disease type I	Pathogenic(Last reviewed: Feb 1, 2020)	criteria provided, single submitter	VCV000004310	1	155204848	1	155235057	4310	19349	rs121908301	NC_000001.11:155235056:C:T
NM_000157.4(GBA):c.481C>T (p.Pro161Ser)	GBA|LOC106627981	P161S, P112S, P74S	Gaucher disease type I	Pathogenic(Last reviewed: Jun 15, 1993)	no assertion criteria provided	VCV000004308	1	155208415	1	155238624	4308	19347	rs121908299	NC_000001.11:155238623:G:A
NM_000157.4(GBA):c.73del (p.Leu25fs)	GBA	L25fs	Gaucher disease type I	Pathogenic(Last reviewed: Jun 15, 1993)	no assertion criteria provided	VCV000004307	1	155210463	1	155240672	4307	19346	rs397518433	NC_000001.11:155240671:GG:G
NM_000157.4(GBA):c.1085C>T (p.Thr362Ile)	GBA|LOC106627981	T362I, T275I, T313I	Gaucher disease type II|Gaucher disease type I|Gaucher disease	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000004306	1	155206175	1	155236384	4306	19345	rs76539814	NC_000001.11:155236383:G:A
NM_000157.4(GBA):c.983C>T (p.Pro328Leu)	GBA|LOC106627981	P328L, P279L, P241L	Gaucher disease type I	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000004305	1	155207148	1	155237357	4305	19344	rs121908298	NC_000001.11:155237356:G:A
NM_000157.4(GBA):c.1309G>T (p.Val437Phe)	GBA|LOC106627981	V398F, V437F, V388F, V350F	Gaucher disease, perinatal lethal	Pathogenic(Last reviewed: May 1, 1999)	no assertion criteria provided	VCV000004303	1	155205551	1	155235760	4303	19342	rs121908310	NC_000001.11:155235759:C:A
NM_000157.4(GBA):c.84dup (p.Leu29fs)	GBA	L29fs	Gaucher disease|Hereditary late onset Parkinson disease|Gaucher disease type I|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|not provided	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004302	1	155210451 - 155210452	1	155240660 - 155240661	4302	19341	rs387906315	NC_000001.11:155240660:C:CC
NM_000157.4(GBA):c.754T>A (p.Phe252Ile)	GBA|LOC106627981	F252I, F165I, F203I	Gaucher disease type I|Gaucher disease type III|not provided|Gaucher disease|Gaucher disease type II	Pathogenic(Last reviewed: Feb 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004301	1	155207932	1	155238141	4301	19340	rs381737	NC_000001.11:155238140:A:T
NM_000157.4(GBA):c.586A>C (p.Lys196Gln)	GBA|LOC106627981	K196Q, K109Q, K147Q	not provided|Gaucher disease type I	Conflicting interpretations of pathogenicity(Last reviewed: Jul 1, 1991)	no assertion criteria provided	VCV000004300	1	155208310	1	155238519	4300	19339	rs121908297	NC_000001.11:155238518:T:G
NM_001005741.2(GBA):c.[535G>C;c.1093G>A]	LOC106627981|GBA	E365K, E278K, E316K, D179H, D130H, D92H	Gaucher disease type I	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000004299	1|1	155206167	1|1	155236376	4299	38432|19338	rs2230288|rs147138516	NC_000001.11:155236375:C:T|NC_000001.11:155238569:C:G
NM_000157.4(GBA):c.764T>A (p.Phe255Tyr)	GBA|LOC106627981	F255Y, F168Y, F206Y	Parkinson disease, late-onset|not provided|Gaucher disease|Hereditary late onset Parkinson disease|Gaucher disease type I|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004298	1	155207367	1	155237576	4298	19337	rs74500255	NC_000001.11:155237575:A:T
NM_001005741.2(GBA):c.[1448T>C;1483G>C;1497G>C]	GBA|LOC106627981	L483P, L396P, L434P, A495P, A408P, A446P	Gaucher disease type III|Gaucher disease type I|Gaucher disease, perinatal lethal|Gaucher disease type II|Hereditary late onset Parkinson disease	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV000004297	1|1|1	155205043	1|1|1	155235252	4297	19327|38384|38385	rs421016|rs368060|rs1135675	NC_000001.11:155235251:A:G|NC_000001.11:155235216:C:G|NC_000001.11:155235202:C:G
NM_000157.4(GBA):c.254G>A (p.Gly85Glu)	GBA|LOC106627981	G85E	Gaucher disease type I|Gaucher disease	Pathogenic(Last reviewed: Sep 21, 2017)	criteria provided, single submitter	VCV000004296	1	155209730	1	155239939	4296	19335	rs77829017	NC_000001.11:155239938:C:T
NM_000157.4(GBA):c.1504C>T (p.Arg502Cys)	GBA|LOC106627981	R502C, R415C, R453C	Parkinson disease, late-onset|Gaucher disease type III|not provided|Gaucher disease type II|Hereditary late onset Parkinson disease|Gaucher disease type I|Gaucher disease|Lewy body dementia|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Parkinson disease, late-onset|Gaucher disease type 3C|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C	Pathogenic(Last reviewed: May 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004295	1	155204987	1	155235196	4295	19334	rs80356771	NC_000001.11:155235195:G:A
NM_000157.4(GBA):c.1343A>T (p.Asp448Val)	GBA|LOC106627981	D448V, D361V, D399V	Gaucher disease type I|Gaucher disease type III|Gaucher disease	Likely pathogenic(Last reviewed: Dec 21, 2015)	criteria provided, single submitter	VCV000004294	1	155205517	1	155235726	4294	19333	rs77369218	NC_000001.11:155235725:T:A
NM_000157.4(GBA):c.1342G>C (p.Asp448His)	GBA|LOC106627981	D448H, D361H, D399H	Gaucher disease|Gaucher disease type II|Gaucher disease type III|Hereditary late onset Parkinson disease|Gaucher disease type I|Gaucher disease type 3C|Gaucher disease, perinatal lethal|Lewy body dementia|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Parkinson disease, late-onset|Gaucher disease type 3C|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004293	1	155205518	1	155235727	4293	19332	rs1064651	NC_000001.11:155235726:C:G
NM_000157.4(GBA):c.1297G>T (p.Val433Leu)	GBA|LOC106627981	V433L, V384L, V346L	Lewy body dementia|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease, perinatal lethal|Gaucher disease type 3C|Parkinson disease, late-onset|Gaucher disease|Gaucher disease type I|Gaucher disease type III|not provided|Hereditary late onset Parkinson disease|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004292	1	155205563	1	155235772	4292	19331	rs80356769	NC_000001.11:155235771:C:A
NM_000157.4(GBA):c.476G>A (p.Arg159Gln)	GBA|LOC106627981	R159Q, R110Q, R72Q	Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Gaucher disease	Pathogenic/Likely pathogenic(Last reviewed: May 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004291	1	155208420	1	155238629	4291	19330	rs79653797	NC_000001.11:155238628:C:T
NM_000157.4(GBA):c.1226A>G (p.Asn409Ser)	GBA|LOC106627981	N409S, N322S, N360S	Thrombocytopenia|Abnormal bleeding|Parkinson disease, late-onset|none provided|Gaucher disease|Gaucher disease, perinatal lethal|Akinesia|Rigidity|Hereditary late onset Parkinson disease|Gaucher disease type I|Parkinson disease|Susceptibility to Parkinson disease|Dementia, Lewy body, susceptibility to|Lewy body dementia|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Parkinson disease, late-onset|Gaucher disease type 3C|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|not provided	Pathogenic/Likely pathogenic, risk factor(Last reviewed: Sep 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004290	1	155205634	1	155235843	4290	19329	rs76763715	NC_000001.11:155235842:T:C
NM_000157.3(GBA):c.1448T>C	GBA|LOC106627981	L483P, L396P, L434P	not provided|Parkinson disease, late-onset|Gaucher disease type III|Hypomimic face|Parkinsonism|Movement disorder|Thoracolumbar scoliosis|Resting tremor|Gaucher disease type II|Hereditary late onset Parkinson disease|Gaucher disease|Dementia, Lewy body, susceptibility to|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C	Pathogenic, risk factor(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004288	1	155205043	1	155235252	4288	19327	rs421016	NC_000001.11:155235251:A:G
NM_000520.6(HEXA):c.1274_1277dup (p.Tyr427fs)	HEXA	Y427fs, Y438fs	not provided|Tay-Sachs disease|Inborn genetic diseases|Tay-Sachs disease|Tay-Sachs disease, variant AB|Intellectual disability	Pathogenic(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000003889	15	72638921 - 72638924	15	72346579 - 72346580	3889	18928	rs387906309	NC_000015.10:72346579:GATA:GATAGATA
NM_000203.5(IDUA):c.590-7G>A	IDUA		Mucopolysaccharidosis type 1|Hurler syndrome|Mucopolysaccharidosis, MPS-I-S	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000222996	4	995460	4	1001672	222996	224715	rs762411583	NC_000004.12:1001671:G:A
NM_000235.4(LIPA):c.894G>C (p.Gln298His)	LIPA	Q298H, Q182H	Lysosomal acid lipase deficiency	Likely pathogenic(Last reviewed: Jul 4, 2017)	no assertion criteria provided	VCV000430634	10	90982268	10	89222511	430634	423865	rs116928232	NC_000010.11:89222510:C:G
NM_000265.7(NCF1):c.75_76del (p.Tyr26fs)	LOC106029312|NCF1	Y26fs	Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 1|not provided	Pathogenic(Last reviewed: Jul 1, 2020)	criteria provided, single submitter	VCV000002249	7	74191613 - 74191614	7	74777267 - 74777268	2249	17288	rs4029402	NC_000007.14:74777266:GTGT:GT
NM_000157.4(GBA):c.1474G>A (p.Asp492Asn)	LOC106627981|GBA	D405N, D443N, D492N	Gaucher disease type I	Uncertain significance(Last reviewed: Jul 22, 2021)	criteria provided, single submitter	VCV001210415	1	155205017	1	155235226	1210415	1200415		NC_000001.11:155235225:C:T
NM_000157.4(GBA):c.1346C>T (p.Thr449Met)	LOC106627981|GBA	T362M, T400M, T449M	Gaucher disease type II|Gaucher disease type I	Uncertain significance(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV001199281	1	155205514	1	155235723	1199281	1189261		NC_000001.11:155235722:G:A
NM_000157.4(GBA):c.167T>A (p.Val56Asp)	LOC106627981|GBA	V56D	Gaucher disease	Uncertain significance(Last reviewed: Aug 15, 2020)	no assertion criteria provided	VCV000991729	1	155209817	1	155240026	991729	977449		NC_000001.11:155240025:A:T
NM_000157.4(GBA):c.171C>T (p.Cys57=)	LOC106627981|GBA		Gaucher disease	Uncertain significance(Last reviewed: Aug 14, 2020)	no assertion criteria provided	VCV000991408	1	155209813	1	155240022	991408	977448		NC_000001.11:155240021:G:A
NM_000157.4(GBA):c.175G>A (p.Ala59Thr)	LOC106627981|GBA	A59T	Gaucher disease	Uncertain significance(Last reviewed: Aug 13, 2020)	no assertion criteria provided	VCV000991407	1	155209809	1	155240018	991407	977447		NC_000001.11:155240017:C:T
NM_000157.4(GBA):c.334C>T (p.Gln112Ter)	LOC106627981|GBA	Q112*, Q25*	Gaucher disease	Pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV000984479	1	155209527	1	155239736	984479	972537		NC_000001.11:155239735:G:A
NM_000157.4(GBA):c.1214G>C (p.Ser405Thr)	LOC106627981|GBA	S405T, S318T, S356T	Gaucher disease type I	Likely pathogenic	no assertion criteria provided	VCV000932297	1	155206046	1	155236255	932297	920600		NC_000001.11:155236254:C:G
NM_000157.4(GBA):c.894C>A (p.Phe298Leu)	LOC106627981|GBA	F211L, F249L, F298L	Gaucher disease	Likely pathogenic(Last reviewed: May 17, 2020)	criteria provided, single submitter	VCV000932200	1	155207237	1	155237446	932200	920479		NC_000001.11:155237445:G:T
NM_000157.4(GBA):c.661C>A (p.Pro221Thr)	LOC106627981|GBA	P134T, P172T, P221T	Gaucher disease	Likely pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV000932181	1	155208025	1	155238234	932181	920480		NC_000001.11:155238233:G:T
NM_000157.4(GBA):c.706C>T (p.Leu236Phe)	LOC106627981|GBA	L149F, L187F, L236F	not specified|not provided	Uncertain significance(Last reviewed: Mar 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000929061	1	155207980	1	155238189	929061	916794		NC_000001.11:155238188:G:A
NM_000157.4(GBA):c.1077C>A (p.Ala359=)	LOC106627981|GBA		Gaucher disease type I	Uncertain significance(Last reviewed: Jun 2, 2020)	no assertion criteria provided	VCV000917860	1	155206183	1	155236392	917860	906180		NC_000001.11:155236391:G:T
NM_000157.4(GBA):c.509G>A (p.Arg170His)	LOC106627981|GBA	R83H, R121H, R170H	Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III	Likely pathogenic	criteria provided, single submitter	VCV000813341	1	155208387	1	155238596	813341	801587	rs80356763	NC_000001.11:155238595:C:T
NM_000157.4(GBA):c.913C>G (p.Pro305Ala)	LOC106627981|GBA	P256A, P218A, P305A	Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III	Likely pathogenic	criteria provided, single submitter	VCV000813340	1	155207218	1	155237427	813340	801586	rs770796008	NC_000001.11:155237426:G:C
NM_000157.4(GBA):c.168C>T (p.Val56=)	LOC106627981|GBA		Gaucher disease type I|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 14, 2021)	criteria provided, conflicting interpretations	VCV000806231	1	155209816	1	155240025	806231	794439	rs145773486	NC_000001.11:155240024:G:A
NM_000157.4(GBA):c.902G>A (p.Arg301His)	LOC106627981|GBA	R301H, R252H, R214H	not provided	Uncertain significance(Last reviewed: Mar 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000592663	1	155207229	1	155237438	592663	583728	rs140955685	NC_000001.11:155237437:C:T
NM_000157.4(GBA):c.589-86A>G	LOC106627981|GBA		Gaucher disease|not provided	Benign(Last reviewed: Jul 5, 2017)	criteria provided, single submitter	VCV000496083	1	155208183	1	155238392	496083	486840	rs2974923	NC_000001.11:155238391:T:C
NM_000157.4(GBA):c.1447C>T (p.Leu483=)	LOC106627981|GBA		Gaucher disease|not specified	Likely benign(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000496082	1	155205044	1	155235253	496082	486837	rs369966551	NC_000001.11:155235252:G:A
NM_000157.4(GBA):c.1296G>A (p.Trp432Ter)	LOC106627981|GBA	W432*, W345*, W383*	Gaucher disease|not provided	Uncertain significance(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000493049	1	155205564	1	155235773	493049	486012	rs1484043383	NC_000001.11:155235772:C:T
NM_000157.4(GBA):c.835C>G (p.Leu279Val)	LOC106627981|GBA	L279V, L192V, L230V	Gaucher disease type III	Uncertain significance(Last reviewed: Dec 21, 2015)	no assertion criteria provided	VCV000375274	1	155207296	1	155237505	375274	362045	rs1057519020	NC_000001.11:155237504:G:C
NM_000157.4(GBA):c.637C>T (p.Leu213Phe)	LOC106627981|GBA	L213F, L126F, L164F	not provided|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C	Conflicting interpretations of pathogenicity(Last reviewed: Jul 16, 2015)	criteria provided, conflicting interpretations	VCV000281587	1	155208049	1	155238258	281587	265824	rs374591570	NC_000001.11:155238257:G:A
NM_000157.4(GBA):c.535G>C (p.Asp179His)	LOC106627981|GBA	D179H, D130H, D92H	not provided|Gaucher disease	Conflicting interpretations of pathogenicity(Last reviewed: Oct 2, 2020)	criteria provided, conflicting interpretations	VCV000242811	1	155208361	1	155238570	242811	19338	rs147138516	NC_000001.11:155238569:C:G
NM_000157.3(GBA):c.1603C>T	LOC106627981|GBA	R535C, R448C, R486C	Gaucher disease type I|Gaucher disease	Pathogenic(Last reviewed: Mar 1, 2020)	criteria provided, single submitter	VCV000242383	1	155204794	1	155235003	242383	237954	rs747506979	NC_000001.11:155235002:G:A
NM_000157.4(GBA):c.1459G>A (p.Ala487Thr)	LOC106627981|GBA	A487T, A400T, A438T	Gaucher disease type I	Likely pathogenic(Last reviewed: Aug 25, 2015)	no assertion criteria provided	VCV000236402	1	155205032	1	155235241	236402	237955	rs878853317	NC_000001.11:155235240:C:T
NM_000157.4(GBA):c.1177C>G (p.Leu393Val)	LOC106627981|GBA	L393V, L306V, L344V	Gaucher disease type I	Likely pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000236400	1	155206083	1	155236292	236400	237958	rs878853315	NC_000001.11:155236291:G:C
NM_000157.4(GBA):c.415G>C (p.Ala139Pro)	LOC106627981|GBA	A139P, A52P	Gaucher disease type I	Likely pathogenic(Last reviewed: Dec 17, 2013)	no assertion criteria provided	VCV000236399	1	155209446	1	155239655	236399	237960	rs878853314	NC_000001.11:155239654:C:G
NM_000157.4(GBA):c.1171G>C (p.Val391Leu)	LOC106627981|GBA	V391L, V304L, V342L	not provided|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Gaucher disease	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000093446	1	155206089	1	155236298	93446	99353	rs398123527	NC_000001.11:155236297:C:G
NM_000157.4(GBA):c.1319C>T (p.Pro440Leu)	LOC106627981|GBA	P440L, P391L, P353L	Gaucher disease type I	Pathogenic(Last reviewed: Jun 4, 1999)	no assertion criteria provided	VCV000004324	1	155205541	1	155235750	4324	19363	rs74598136	NC_000001.11:155235749:G:A
NM_000157.4(GBA):c.1174C>G (p.Arg392Gly)	LOC106627981|GBA	R392G, R343G, R305G	Gaucher disease type III	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000004323	1	155206086	1	155236295	4323	19362	rs121908308	NC_000001.11:155236294:G:C
NM_000157.4(GBA):c.1141T>G (p.Cys381Gly)	LOC106627981|GBA	C381G, C332G, C294G	Gaucher disease type II	Pathogenic(Last reviewed: Dec 15, 1990)	no assertion criteria provided	VCV000004319	1	155206119	1	155236328	4319	19358	rs121908306	NC_000001.11:155236327:A:C
NM_000157.4(GBA):c.1043C>T (p.Ala348Val)	LOC106627981|GBA	A348V, A299V, A261V	Gaucher disease type I	Pathogenic(Last reviewed: Jul 1, 1990)	no assertion criteria provided	VCV000004316	1	155206217	1	155236426	4316	19355	rs78396650	NC_000001.11:155236425:G:A
NM_000157.4(GBA):c.751T>C (p.Tyr251His)	LOC106627981|GBA	Y251H, Y202H, Y164H	Gaucher disease|Gaucher disease type I	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2020)	no assertion criteria provided	VCV000004309	1	155207935	1	155238144	4309	19348	rs121908300	NC_000001.11:155238143:A:G
NM_000157.4(GBA):c.1361C>G (p.Pro454Arg)	LOC106627981|GBA	P454R, P405R, P367R	Gaucher disease type II	Pathogenic(Last reviewed: Nov 16, 2007)	no assertion criteria provided	VCV000004289	1	155205499	1	155235708	4289	19328	rs121908295	NC_000001.11:155235707:G:C
NM_000179.3(MSH6):c.3822dup (p.Cys1275fs)	MSH6	C973fs, C1145fs, C1275fs	Gaucher disease type I	Likely pathogenic(Last reviewed: Apr 4, 2012)	no assertion criteria provided	VCV000446214	2	48033609 - 48033610	2	47806470 - 47806471	446214	439575	rs1553333346	NC_000002.12:47806470:AA:AAA
NM_001384140.1(PCDH15):c.733C>T (p.Arg245Ter)	PCDH15	R245*, R208*, R223*, R250*	Usher syndrome, type 1G|Usher syndrome type 1F|Deafness, autosomal recessive 23|Usher syndrome type 1D|not provided|Usher syndrome type 1|Rare genetic deafness|Usher syndrome type 1D|Usher syndrome type 1F|Deafness, autosomal recessive 23	Pathogenic(Last reviewed: Feb 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004933	10	56077174	10	54317414	4933	19972	rs111033260	NC_000010.11:54317413:G:A
NM_000444.6(PHEX):c.1765_1768del (p.Asn589fs)	PHEX|PTCHD1-AS	N589fs	not provided	Pathogenic(Last reviewed: Sep 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000420129	X	22237217 - 22237220	X	22219100 - 22219103	420129	411286	rs1064794305	NC_000023.11:22219099:AATG:
NM_000444.6(PHEX):c.1768+2dup	PHEX|PTCHD1-AS		not provided	Likely pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	VCV000372462	X	22237221 - 22237222	X	22219104 - 22219105	372462	360683	rs1057517796	NC_000023.11:22219104:T:TT
NM_000444.6(PHEX):c.2138dup (p.Gln714fs)	PHEX|PTCHD1-AS	Q714fs	not provided	Likely pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, single submitter	VCV000280088	X	22263512 - 22263513	X	22245395 - 22245396	280088	265089	rs886041375	NC_000023.11:22245395:CCCCC:CCCCCC
NM_000444.6(PHEX):c.1989_1990del (p.Asp663fs)	PHEX|PTCHD1-AS	D663fs	not provided	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000280084	X	22245646 - 22245647	X	22227529 - 22227530	280084	265083	rs886041371	NC_000023.11:22227528:ACA:A
NM_000444.6(PHEX):c.1854_1857dup (p.Asn620delinsAspTer)	PHEX|PTCHD1-AS		Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280080	X	22239813 - 22239814	X	22221696 - 22221697	280080	265081	rs886041367	NC_000023.11:22221696:TGATT:TGATTGATT
NM_000444.6(PHEX):c.1843dup (p.Thr615fs)	PHEX|PTCHD1-AS	T615fs	not provided	Pathogenic(Last reviewed: Dec 20, 2016)	criteria provided, multiple submitters, no conflicts	VCV000280079	X	22239798 - 22239799	X	22221681 - 22221682	280079	265080	rs886041366	NC_000023.11:22221681:AAAAAA:AAAAAAA
NM_000444.6(PHEX):c.1806G>A (p.Trp602Ter)	PHEX|PTCHD1-AS	W602*	not provided	Pathogenic(Last reviewed: May 27, 2016)	criteria provided, single submitter	VCV000280078	X	22239767	X	22221650	280078	265150	rs886041365	NC_000023.11:22221649:G:A
NM_000444.6(PHEX):c.538del (p.Trp180fs)	PHEX	W180fs	not provided	Pathogenic(Last reviewed: Jun 28, 2016)	criteria provided, single submitter	VCV000265500	X	22095693	X	22077575	265500	260297	rs886039581	NC_000023.11:22077574:TTT:TT
NM_002778.4(PSAP):c.1076A>C (p.Glu359Ala)	PSAP	E359A, E361A, E362A	Metachromatic leukodystrophy|Gaucher disease, atypical, due to saposin C deficiency	Likely pathogenic(Last reviewed: Apr 14, 2021)	criteria provided, single submitter	VCV000991967	10	73579587	10	71819830	991967	978787		NC_000010.11:71819829:T:G
NM_002778.4(PSAP):c.*596A>G	PSAP		Krabbe disease, atypical, due to saposin A deficiency|Gaucher disease, atypical, due to saposin C deficiency|Combined saposin deficiency|Sphingolipid activator protein 1 deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000880453	10	73576602	10	71816845	880453	866171		NC_000010.11:71816844:T:C
NM_002778.4(PSAP):c.419C>T (p.Ser140Phe)	PSAP	S140F	Krabbe disease, atypical, due to saposin A deficiency|Gaucher disease, atypical, due to saposin C deficiency|Combined saposin deficiency|Sphingolipid activator protein 1 deficiency	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000879866	10	73588791	10	71829034	879866	866182		NC_000010.11:71829033:G:A
NM_002778.4(PSAP):c.423C>T (p.Leu141=)	PSAP		Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Sep 15, 2020)	criteria provided, conflicting interpretations	VCV000879500	10	73588787	10	71829030	879500	866181		NC_000010.11:71829029:G:A
NM_002778.4(PSAP):c.508C>G (p.Pro170Ala)	PSAP	P170A	Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000879499	10	73588702	10	71828945	879499	866180		NC_000010.11:71828944:G:C
NM_002778.4(PSAP):c.1197C>T (p.His399=)	PSAP		Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Oct 20, 2020)	criteria provided, conflicting interpretations	VCV000879388	10	73579375	10	71819618	879388	866178		NC_000010.11:71819617:G:A
NM_002778.4(PSAP):c.*737G>A	PSAP		Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000879264	10	73576461	10	71816704	879264	866170		NC_000010.11:71816703:C:T
NM_002778.4(PSAP):c.1329G>T (p.Leu443=)	PSAP		Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000878804	10	73579243	10	71819486	878804	866177		NC_000010.11:71819485:C:A
NM_002778.4(PSAP):c.*346C>T	PSAP		Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000878721	10	73576852	10	71817095	878721	866174		NC_000010.11:71817094:G:A
NM_002778.4(PSAP):c.*787C>T	PSAP		Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000878665	10	73576411	10	71816654	878665	866169		NC_000010.11:71816653:G:A
NM_002778.4(PSAP):c.249+6C>T	PSAP		Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000878088	10	73591597	10	71831840	878088	868499		NC_000010.11:71831839:G:A
NM_002778.4(PSAP):c.565C>T (p.Pro189Ser)	PSAP	P189S	Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000878037	10	73588645	10	71828888	878037	866179		NC_000010.11:71828887:G:A
NM_002778.4(PSAP):c.*90C>T	PSAP		Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000877730	10	73577108	10	71817351	877730	866176		NC_000010.11:71817350:G:A
NM_002778.4(PSAP):c.*376A>G	PSAP		Combined saposin deficiency|Krabbe disease, atypical, due to saposin A deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000877693	10	73576822	10	71817065	877693	866173		NC_000010.11:71817064:T:C
NM_002778.4(PSAP):c.*526G>A	PSAP		Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000877692	10	73576672	10	71816915	877692	866172		NC_000010.11:71816914:C:T
NM_002778.4(PSAP):c.*1008C>T	PSAP		Combined saposin deficiency|Krabbe disease, atypical, due to saposin A deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000877646	10	73576190	10	71816433	877646	866168		NC_000010.11:71816432:G:A
NM_002778.4(PSAP):c.1146C>T (p.Cys382=)	PSAP		Metachromatic leukodystrophy|Sphingolipid activator protein 1 deficiency|Gaucher disease, atypical, due to saposin C deficiency|Combined saposin deficiency|Krabbe disease, atypical, due to saposin A deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Nov 13, 2020)	criteria provided, conflicting interpretations	VCV000765408	10	73579517	10	71819760	765408	767962	rs573095617	NC_000010.11:71819759:G:A
NM_002778.4(PSAP):c.1369G>T (p.Glu457Ter)	PSAP	E460*, E459*, E457*	Combined saposin deficiency|Krabbe disease, atypical, due to saposin A deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency	Pathogenic(Last reviewed: Jun 18, 2013)	no assertion criteria provided	VCV000438801	10	73578850	10	71819093	438801	432427	rs1554879741	NC_000010.11:71819092:C:A
NM_001042465.2(PSAP):c.-118G>A	PSAP		Galactosylceramide beta-galactosidase deficiency|Combined saposin deficiency|Metachromatic leukodystrophy|Atypical Gaucher Disease	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000368924	10	73611096	10	71851339	368924	353153	rs28365838	NC_000010.11:71851338:C:T
NM_002778.3(PSAP):c.-99T>G	PSAP		Metachromatic leukodystrophy|Combined saposin deficiency|Atypical Gaucher Disease|Galactosylceramide beta-galactosidase deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300547	10	73611077	10	71851320	300547	310811	rs886047156	NC_000010.11:71851319:A:C
NM_002778.3(PSAP):c.-65C>T	PSAP		Metachromatic leukodystrophy|Combined saposin deficiency|Atypical Gaucher Disease|Galactosylceramide beta-galactosidase deficiency	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300546	10	73611043	10	71851286	300546	310808	rs145948209	NC_000010.11:71851285:G:A
NM_002778.3(PSAP):c.-62A>G	PSAP		Metachromatic leukodystrophy|Combined saposin deficiency|Atypical Gaucher Disease|Galactosylceramide beta-galactosidase deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300545	10	73611040	10	71851283	300545	322166	rs886047155	NC_000010.11:71851282:T:C
NM_002778.3(PSAP):c.-56A>G	PSAP		Metachromatic leukodystrophy|Combined saposin deficiency|Atypical Gaucher Disease|Galactosylceramide beta-galactosidase deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300544	10	73611034	10	71851277	300544	322165	rs534586960	NC_000010.11:71851276:T:C
NM_002778.3(PSAP):c.-50G>T	PSAP		Metachromatic leukodystrophy|Combined saposin deficiency|Atypical Gaucher Disease|Galactosylceramide beta-galactosidase deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300543	10	73611028	10	71851271	300543	316063	rs886047154	NC_000010.11:71851270:C:A
NM_002778.3(PSAP):c.-33T>C	PSAP		Metachromatic leukodystrophy|Combined saposin deficiency|Atypical Gaucher Disease|Galactosylceramide beta-galactosidase deficiency	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300542	10	73611011	10	71851254	300542	310806	rs143987544	NC_000010.11:71851253:A:G
NM_002778.4(PSAP):c.-29C>T	PSAP		Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Likely benign(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000300541	10	73611007	10	71851250	300541	316062	rs201780377	NC_000010.11:71851249:G:A
NM_002778.4(PSAP):c.-22G>C	PSAP		Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300540	10	73611000	10	71851243	300540	310804	rs569841336	NC_000010.11:71851242:C:G
NM_002778.4(PSAP):c.40+12G>A	PSAP		Sphingolipid activator protein 1 deficiency|Gaucher disease, atypical, due to saposin C deficiency|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300539	10	73610927	10	71851170	300539	322779	rs886047153	NC_000010.11:71851169:C:T
NM_002778.4(PSAP):c.41-13G>C	PSAP		Sphingolipid activator protein 1 deficiency|Gaucher disease, atypical, due to saposin C deficiency|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000300538	10	73594275	10	71834518	300538	310803	rs138010978	NC_000010.11:71834517:C:G
NM_002778.4(PSAP):c.78C>T (p.Thr26=)	PSAP		Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Benign(Last reviewed: Nov 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000300537	10	73594225	10	71834468	300537	322778	rs74145688	NC_000010.11:71834467:G:A
NM_002778.4(PSAP):c.88G>T (p.Ala30Ser)	PSAP	A30S	Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|not provided|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2020)	criteria provided, conflicting interpretations	VCV000300536	10	73594215	10	71834458	300536	310793	rs144942998	NC_000010.11:71834457:C:A
NM_002778.4(PSAP):c.94T>G (p.Trp32Gly)	PSAP	W32G	Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000300535	10	73594209	10	71834452	300535	310792	rs200008050	NC_000010.11:71834451:A:C
NM_002778.4(PSAP):c.112A>T (p.Thr38Ser)	PSAP	T38S	Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000300534	10	73594191	10	71834434	300534	322777	rs535525554	NC_000010.11:71834433:T:A
NM_002778.4(PSAP):c.167C>G (p.Pro56Arg)	PSAP	P56R	Atypical Gaucher Disease|Combined saposin deficiency|Galactosylceramide beta-galactosidase deficiency|Metachromatic leukodystrophy	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300533	10	73594136	10	71834379	300533	322776	rs571773332	NC_000010.11:71834378:G:C
NM_002778.4(PSAP):c.174+9C>T	PSAP		Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000300532	10	73594120	10	71834363	300532	310781	rs141133813	NC_000010.11:71834362:G:A
NM_002778.4(PSAP):c.189C>T (p.Cys63=)	PSAP		Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 28, 2020)	criteria provided, conflicting interpretations	VCV000300531	10	73591663	10	71831906	300531	322152	rs111369573	NC_000010.11:71831905:G:A
NM_002778.4(PSAP):c.204C>T (p.Asp68=)	PSAP		Krabbe disease, atypical, due to saposin A deficiency|Metachromatic leukodystrophy|Combined saposin deficiency|Sphingolipid activator protein 1 deficiency|Gaucher disease, atypical, due to saposin C deficiency	Benign/Likely benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000300530	10	73591648	10	71831891	300530	316059	rs143981174	NC_000010.11:71831890:G:A
NM_002778.4(PSAP):c.227T>A (p.Met76Lys)	PSAP	M76K	Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000300529	10	73591625	10	71831868	300529	316058	rs377024801	NC_000010.11:71831867:A:T
NM_002778.4(PSAP):c.250-12G>A	PSAP		Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300528	10	73591020	10	71831263	300528	322775	rs886047152	NC_000010.11:71831262:C:T
NM_002778.4(PSAP):c.336C>T (p.Ser112=)	PSAP		Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Benign/Likely benign(Last reviewed: Nov 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000300527	10	73590922	10	71831165	300527	310779	rs370977178	NC_000010.11:71831164:G:A
NM_002778.4(PSAP):c.380G>A (p.Arg127His)	PSAP	R127H	Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000300526	10	73588830	10	71829073	300526	310774	rs886047151	NC_000010.11:71829072:C:T
NM_002778.4(PSAP):c.557G>A (p.Arg186His)	PSAP	R186H	Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000300525	10	73588653	10	71828896	300525	322766	rs138880818	NC_000010.11:71828895:C:T
NM_002778.4(PSAP):c.570G>T (p.Gln190His)	PSAP	Q190H	Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Galactosylceramide beta-galactosidase deficiency|not provided|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Benign/Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000300524	10	73588640	10	71828883	300524	322147	rs142272618	NC_000010.11:71828882:C:A
NM_002778.4(PSAP):c.577-10T>C	PSAP		Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000300523	10	73587924	10	71828167	300523	316055	rs185892516	NC_000010.11:71828166:A:G
NM_002778.4(PSAP):c.714C>G (p.Ala238=)	PSAP		Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)	criteria provided, conflicting interpretations	VCV000300522	10	73587777	10	71828020	300522	322761	rs141199649	NC_000010.11:71828019:G:C
NM_002778.4(PSAP):c.798G>A (p.Ala266=)	PSAP		Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000300521	10	73581744	10	71821987	300521	322126	rs199672678	NC_000010.11:71821986:C:T
NM_002778.4(PSAP):c.911A>G (p.Lys304Arg)	PSAP	K307R, K304R, K306R	Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000300520	10	73580091	10	71820334	300520	310773	rs757553906	NC_000010.11:71820333:T:C
NM_002778.4(PSAP):c.923C>T (p.Pro308Leu)	PSAP	P308L, P311L, P310L	Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300519	10	73580079	10	71820322	300519	322124	rs886047150	NC_000010.11:71820321:G:A
NM_002778.4(PSAP):c.1000A>T (p.Thr334Ser)	PSAP	T334S, T337S, T336S	Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000300518	10	73580002	10	71820245	300518	316053	rs749663645	NC_000010.11:71820244:T:A
NM_002778.4(PSAP):c.1012A>G (p.Ile338Val)	PSAP	I341V, I338V, I340V	Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000300517	10	73579651	10	71819894	300517	322118	rs544300820	NC_000010.11:71819893:T:C
NM_002778.4(PSAP):c.1056C>T (p.Ser352=)	PSAP		Krabbe disease, atypical, due to saposin A deficiency|Metachromatic leukodystrophy|Atypical Gaucher Disease|Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Galactosylceramide beta-galactosidase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Nov 23, 2020)	criteria provided, conflicting interpretations	VCV000300516	10	73579607	10	71819850	300516	310771	rs138328594	NC_000010.11:71819849:G:A
NM_002778.4(PSAP):c.1088C>T (p.Thr363Met)	PSAP	T363M, T366M, T365M	Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|not provided|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jan 22, 2019)	criteria provided, conflicting interpretations	VCV000300515	10	73579575	10	71819818	300515	322116	rs140066253	NC_000010.11:71819817:G:A
NM_002778.4(PSAP):c.1172C>T (p.Thr391Met)	PSAP	T394M, T391M, T393M	Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Nov 19, 2019)	criteria provided, conflicting interpretations	VCV000300514	10	73579491	10	71819734	300514	310768	rs202125074	NC_000010.11:71819733:G:A
NM_002778.4(PSAP):c.1258G>A (p.Asp420Asn)	PSAP	D423N, D420N, D422N	Atypical Gaucher Disease|Combined saposin deficiency|Galactosylceramide beta-galactosidase deficiency|Metachromatic leukodystrophy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300513	10	73579314	10	71819557	300513	322738	rs760621775	NC_000010.11:71819556:C:T
NM_002778.4(PSAP):c.1261C>T (p.Arg421Cys)	PSAP	R421C, R424C, R423C	Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000300512	10	73579311	10	71819554	300512	322732	rs529719024	NC_000010.11:71819553:G:A
NM_002778.4(PSAP):c.1278C>T (p.Asn426=)	PSAP		Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency|Sphingolipid activator protein 1 deficiency|Gaucher disease, atypical, due to saposin C deficiency|Metachromatic leukodystrophy	Conflicting interpretations of pathogenicity(Last reviewed: Sep 12, 2019)	criteria provided, conflicting interpretations	VCV000300511	10	73579294	10	71819537	300511	322114	rs777227555	NC_000010.11:71819536:G:A
NM_002778.4(PSAP):c.1432-4A>G	PSAP		Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jul 3, 2020)	criteria provided, conflicting interpretations	VCV000300510	10	73578485	10	71818728	300510	310757	rs775086571	NC_000010.11:71818727:T:C
NM_002778.4(PSAP):c.1452G>A (p.Ser484=)	PSAP		not provided|Krabbe disease, atypical, due to saposin A deficiency|Gaucher disease, atypical, due to saposin C deficiency|Combined saposin deficiency|Sphingolipid activator protein 1 deficiency|Galactosylceramide beta-galactosidase deficiency	Benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000300509	10	73578461	10	71818704	300509	322729	rs114389264	NC_000010.11:71818703:C:T
NM_002778.4(PSAP):c.1456C>T (p.His486Tyr)	PSAP	H486Y, H489Y, H488Y	Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000300508	10	73578457	10	71818700	300508	316052	rs749660716	NC_000010.11:71818699:G:A
NM_002778.4(PSAP):c.1476T>C (p.Thr492=)	PSAP		Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Nov 1, 2020)	criteria provided, conflicting interpretations	VCV000300507	10	73578437	10	71818680	300507	310754	rs139178900	NC_000010.11:71818679:A:G
NM_002778.4(PSAP):c.*9A>G	PSAP		Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000300506	10	73577189	10	71817432	300506	322728	rs376628499	NC_000010.11:71817431:T:C
NM_002778.4(PSAP):c.*73C>T	PSAP		Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300505	10	73577125	10	71817368	300505	310752	rs541692197	NC_000010.11:71817367:G:A
NM_002778.4(PSAP):c.*113C>T	PSAP		Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300504	10	73577085	10	71817328	300504	310750	rs544214520	NC_000010.11:71817327:G:A
NM_002778.4(PSAP):c.*122C>G	PSAP		Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|not provided|Krabbe disease, atypical, due to saposin A deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jul 9, 2018)	criteria provided, conflicting interpretations	VCV000300503	10	73577076	10	71817319	300503	310749	rs113284884	NC_000010.11:71817318:G:C
NM_002778.4(PSAP):c.*276G>A	PSAP		Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000300502	10	73576922	10	71817165	300502	310748	rs547409137	NC_000010.11:71817164:C:T
NM_002778.4(PSAP):c.*574G>C	PSAP		Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300501	10	73576624	10	71816867	300501	316050	rs549402343	NC_000010.11:71816866:C:G
NM_002778.4(PSAP):c.*775G>A	PSAP		Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|not provided	Benign(Last reviewed: May 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000300500	10	73576423	10	71816666	300500	322113	rs79662404	NC_000010.11:71816665:C:T
NM_002778.4(PSAP):c.*859C>T	PSAP		Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300499	10	73576339	10	71816582	300499	316049	rs886047149	NC_000010.11:71816581:G:A
NM_002778.4(PSAP):c.*935A>G	PSAP		Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency|Krabbe disease, atypical, due to saposin A deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000300497	10	73576263	10	71816506	300497	322727	rs886047148	NC_000010.11:71816505:T:C
NM_022124.6(CDH23):c.*588del	PSAP|CDH23		Retinitis pigmentosa-deafness syndrome|Nonsyndromic Hearing Loss, Recessive|Metachromatic leukodystrophy|Atypical Gaucher Disease|CDH23-Related Disorders|Combined saposin deficiency|Galactosylceramide beta-galactosidase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	VCV000300495	10	73575621	10	71815864	300495	322109	rs148667421	NC_000010.11:71815863:AAA:AA
NM_022124.6(CDH23):c.9942G>A (p.Thr3314=)	PSAP|CDH23		not specified|not provided|Retinitis pigmentosa-deafness syndrome|Nonsyndromic Hearing Loss, Recessive|Atypical Gaucher Disease|CDH23-Related Disorders|Usher syndrome type 1|Combined saposin deficiency|Deafness, autosomal recessive 12|Usher syndrome type 1D|Galactosylceramide beta-galactosidase deficiency|Metachromatic leukodystrophy	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2020)	criteria provided, conflicting interpretations	VCV000300478	10	73574912	10	71815155	300478	322088	rs376804660	NC_000010.11:71815154:G:A
NM_022124.6(CDH23):c.9799C>T (p.Arg3267Cys)	PSAP|CDH23	R3267C, R1027C, R129C, R164C, R992C	Retinitis pigmentosa-deafness syndrome|Metachromatic leukodystrophy|Nonsyndromic Hearing Loss, Recessive|Atypical Gaucher Disease|Combined saposin deficiency|Deafness, autosomal recessive 12|Usher syndrome type 1D|CDH23-Related Disorders|Galactosylceramide beta-galactosidase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000300476	10	73574769	10	71815012	300476	322713	rs201727938	NC_000010.11:71815011:C:T
NM_002778.4(PSAP):c.1380C>T (p.Pro460=)	PSAP		not specified|Galactosylceramide beta-galactosidase deficiency|Krabbe disease, atypical, due to saposin A deficiency|Gaucher disease, atypical, due to saposin C deficiency|Combined saposin deficiency|Sphingolipid activator protein 1 deficiency	Benign/Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000258810	10	73578839	10	71819082	258810	253829	rs1049882	NC_000010.11:71819081:G:A
NM_002778.4(PSAP):c.-4C>T	PSAP		not provided|not specified|Combined saposin deficiency|Krabbe disease, atypical, due to saposin A deficiency|Sphingolipid activator protein 1 deficiency|Gaucher disease, atypical, due to saposin C deficiency	Benign(Last reviewed: Jul 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000258806	10	73610982	10	71851225	258806	253834	rs2070188	NC_000010.11:71851224:G:A
NM_002778.4(PSAP):c.-28A>C	PSAP		not specified|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency|Sphingolipid activator protein 1 deficiency|Gaucher disease, atypical, due to saposin C deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000258805	10	73611006	10	71851249	258805	253836	rs375720661	NC_000010.11:71851248:T:G
NM_002778.4(PSAP):c.-10A>G	PSAP		not provided|not specified|Krabbe disease, atypical, due to saposin A deficiency|Combined saposin deficiency|Gaucher disease, atypical, due to saposin C deficiency|Sphingolipid activator protein 1 deficiency	Benign(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000258804	10	73610988	10	71851231	258804	253835	rs76455588	NC_000010.11:71851230:T:C
NM_002778.4(PSAP):c.1046T>C (p.Leu349Pro)	PSAP	L349P, L352P, L351P	Gaucher disease, atypical, due to saposin C deficiency	Pathogenic(Last reviewed: Oct 26, 2021)	no assertion criteria provided	VCV000013372	10	73579617	10	71819860	13372	28411	rs121918110	NC_000010.11:71819859:A:G
NM_002778.4(PSAP):c.1288C>T (p.Gln430Ter)	PSAP	Q430*, Q433*, Q432*	Gaucher disease, atypical, due to saposin C deficiency	Pathogenic(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000013371	10	73579284	10	71819527	13371	28410	rs121918109	NC_000010.11:71819526:G:A
NM_002778.4(PSAP):c.1144T>G (p.Cys382Gly)	PSAP	C382G, C385G, C384G	Gaucher disease, atypical, due to saposin C deficiency	Pathogenic(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000013370	10	73579519	10	71819762	13370	28409	rs121918108	NC_000010.11:71819761:A:C
NM_002778.4(PSAP):c.1A>T (p.Met1Leu)	PSAP	M1L	Gaucher disease, atypical, due to saposin C deficiency|Combined saposin deficiency	Pathogenic(Last reviewed: Oct 26, 2021)	no assertion criteria provided	VCV000013365	10	73610978	10	71851221	13365	28404	rs121918106	NC_000010.11:71851220:T:A
NM_002778.4(PSAP):c.1145G>T (p.Cys382Phe)	PSAP	C385F, C382F, C384F	Gaucher disease, atypical, due to saposin C deficiency	Pathogenic(Last reviewed: Oct 2, 1989)	no assertion criteria provided	VCV000013364	10	73579518	10	71819761	13364	28403	rs121918105	NC_000010.11:71819760:C:A
NM_000543.5(SMPD1):c.688C>T (p.Arg230Cys)	SMPD1	R230C, R229C	Niemann-Pick disease, type A|Niemann-Pick disease, type A|Niemann-Pick disease, type B|Sphingomyelin/cholesterol lipidosis	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000370432	11	6412983	11	6391753	370432	357985	rs989639224	NC_000011.10:6391752:C:T
NM_000543.5(SMPD1):c.106_107insCGCTGG (p.Val36_Leu37insAlaLeu)	SMPD1		Niemann-Pick disease, type A|Gaucher disease|Niemann-Pick disease, type B|Niemann-Pick disease, type A|Sphingomyelin/cholesterol lipidosis	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000305194	11	6411930 - 6411931	11	6390700 - 6390701	305194	314491	rs1554933800	NC_000011.10:6390700:CTGG:CTGGCGCTGG
NM_000552.5(VWF):c.2447G>A (p.Arg816Gln)	VWF	R816Q	Abnormality of coagulation|not provided	Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000100223	12	6145653	12	6036487	100223	106100	rs62643634	NC_000012.12:6036486:C:T
NM_000552.5(VWF):c.4541T>G (p.Phe1514Cys)	VWF	F1514C	von Willebrand disease, type 2a|not provided	Pathogenic(Last reviewed: May 1, 2010)	no assertion criteria provided	VCV000000304	12	6128043	12	6018877	304	15343	rs61750101	NC_000012.12:6018876:A:C
NM_000552.5(VWF):c.2561G>A (p.Arg854Gln)	VWF	R854Q	Thrombocytopenia|Abnormal bleeding|Abnormality of coagulation|von Willebrand disease type 2|von Willebrand disease type 2N|von Willebrand disease type 1|von Willebrand disorder|not provided|von Willebrand disease type 1|von Willebrand disease type 2|Von Willebrand disease, recessive form	Pathogenic/Likely pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000000296	12	6143978	12	6034812	296	15335	rs41276738	NC_000012.12:6034811:C:T
NM_000552.5(VWF):c.2446C>T (p.Arg816Trp)	VWF	R816W	not provided|von Willebrand disorder|von Willebrand disease type 2N	Pathogenic(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000000295	12	6145654	12	6036488	295	15334	rs121964894	NC_000012.12:6036487:G:A
NM_000552.5(VWF):c.2372C>T (p.Thr791Met)	VWF	T791M	Abnormal bleeding|von Willebrand disease type 2N|not provided	Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000000294	12	6153527	12	6044361	294	15333	rs61748477	NC_000012.12:6044360:G:A
